☰

Karen S. Marder - Publications

Affiliations: 
Neurology Columbia Medical Center, New York, NY, United States 
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

340 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Joyce JL, Chapman S, Waltrip L, Caes D, Gottesman R, Rizer S, Haque H, Golfer L, Mayeux RP, D'Alton ME, Marder K, Rosser M, Cosentino S. Confronting Alzheimer's Disease Risk in Women: A Feasibility Study of Memory Screening as Part of the Annual Gynecological Well-Woman Visit. Journal of Women's Health (2002). PMID 38968392 DOI: 10.1089/jwh.2023.0843  0.346
2023 Agin-Liebes J, Hickman RA, Vonsattel JP, Faust PL, Flowers X, Utkina Sosunova I, Ntiri J, Mayeux R, Surface M, Marder K, Fahn S, Przedborski S, Alcalay RN. Patterns of TDP-43 Deposition in Brains with LRRK2 G2019S Mutations. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 37218402 DOI: 10.1002/mds.29449  0.464
2023 Vollstedt EJ, Schaake S, Lohmann K, Padmanabhan S, Brice A, Lesage S, Tesson C, Vidailhet M, Wurster I, Hentati F, Mirelman A, Giladi N, Marder K, Waters C, Fahn S, et al. Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 36692014 DOI: 10.1002/mds.29288  0.498
2022 Pal G, Mangone G, Hill EJ, Ouyang B, Liu Y, Lythe V, Ehrlich D, Saunders-Pullman R, Shanker V, Bressman S, Alcalay RN, Garcia P, Marder KS, Aasly J, Mouradian MM, et al. Parkinson disease and STN-DBS: cognitive effects in GBA mutation carriers. Annals of Neurology. PMID 34984729 DOI: 10.1002/ana.26302  0.305
2021 Surface M, Balwani M, Waters C, Haimovich A, Gan-Or Z, Marder KS, Hsieh T, Song L, Padmanabhan S, Hsieh F, Merchant KM, Alcalay RN. Plasma Glucosylsphingosine in GBA1 Mutation Carriers with and without Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 34741486 DOI: 10.1002/mds.28846  0.326
2021 Ortega RA, Wang C, Raymond D, Bryant N, Scherzer CR, Thaler A, Alcalay RN, West AB, Mirelman A, Kuras Y, Marder KS, Giladi N, Ozelius LJ, Bressman SB, Saunders-Pullman R. Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease Progression. Jama Network Open. 4: e215845. PMID 33881531 DOI: 10.1001/jamanetworkopen.2021.5845  0.304
2020 Xu Y, Mirelman A, Saunders-Pullman R, Mejia-Santana H, Caccappolo E, Raymond D, Giladi N, Bressman S, Marder K, Alcalay RN. Differences in performance on English and Hebrew versions of the MoCA in Parkinson's patients. Clinical Parkinsonism & Related Disorders. 3. PMID 34095813 DOI: 10.1016/j.prdoa.2020.100042  0.323
2020 Dhanwani R, Pham J, Premlal ALR, Frazier A, Kumar A, Pero ME, Bartolini F, Dutra JR, Marder KS, Peters B, Sulzer D, Sette A, Lindestam Arlehamn CS. T Cell Responses to Neural Autoantigens Are Similar in Alzheimer's Disease Patients and Age-Matched Healthy Controls. Frontiers in Neuroscience. 14: 874. PMID 32982670 DOI: 10.3389/Fnins.2020.00874  0.338
2020 Hickman RA, Vonsattel JP, Agin-Liebes J, Marder K, Alcalay RN. Authors' replies to the comments of Koga et al. on "Movement disorders rounds: A case of missing pathology in a patient with LRRK2 Parkinson's disease". Parkinsonism & Related Disorders. PMID 32928644 DOI: 10.1016/J.Parkreldis.2020.08.037  0.33
2020 Porciuncula F, Wasserman P, Marder KS, Rao AK. Quantifying Postural Control in Premanifest and Manifest Huntington Disease Using Wearable Sensors. Neurorehabilitation and Neural Repair. 1545968320939560. PMID 32672492 DOI: 10.1177/1545968320939560  0.509
2020 McKeith IG, Ferman TJ, Thomas AJ, Blanc F, Boeve BF, Fujishiro H, Kantarci K, Muscio C, O'Brien JT, Postuma RB, Aarsland D, Ballard C, Bonanni L, Donaghy P, Emre M, ... ... Marder KS, et al. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology. PMID 32241955 DOI: 10.1212/Wnl.0000000000009323  0.381
2020 Orme T, Hernandez D, Ross OA, Kun-Rodrigues C, Darwent L, Shepherd CE, Parkkinen L, Ansorge O, Clark L, Honig LS, Marder K, Lemstra A, Rogaeva E, St George-Hyslop P, Londos E, et al. Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies. Acta Neuropathologica Communications. 8: 5. PMID 31996268 DOI: 10.1186/S40478-020-0879-Z  0.433
2019 Agin-Liebes J, Cortes E, Vonsattel JP, Marder K, Alcalay RN. Movement disorders rounds: A case of missing pathology in a patient with LRRK2 Parkinson's disease. Parkinsonism & Related Disorders. PMID 31734038 DOI: 10.1016/J.Parkreldis.2019.11.006  0.379
2019 Alcalay RN, Kehoe C, Shorr E, Battista R, Hall A, Simuni T, Marder K, Wills AM, Naito A, Beck JC, Schwarzschild MA, Nance M. Genetic testing for Parkinson disease: current practice, knowledge, and attitudes among US and Canadian movement disorders specialists. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 31680121 DOI: 10.1038/S41436-019-0684-X  0.355
2019 Agalliu I, Ortega RA, Luciano MS, Mirelman A, Pont-Sunyer C, Brockmann K, Vilas D, Tolosa E, Berg D, Warø B, Glickman A, Raymond D, Inzelberg R, Ruiz-Martinez J, Mondragon E, ... ... Marder K, et al. Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31348549 DOI: 10.1002/Mds.27807  0.432
2019 Kozlovski T, Mitelpunkt A, Thaler A, Gurevich T, Orr-Urtreger A, Gana-Weisz M, Shachar N, Galili T, Marcus-Kalish M, Bressman S, Marder K, Giladi N, Benjamini Y, Mirelman A. Hierarchical Data-Driven Analysis of Clinical Symptoms Among Patients With Parkinson's Disease. Frontiers in Neurology. 10: 531. PMID 31164863 DOI: 10.3389/Fneur.2019.00531  0.419
2019 Anderson KE, Eberly S, Marder KS, Oakes D, Kayson E, Young A, Shoulson I. The choice not to undergo genetic testing for Huntington disease: Results from the PHAROS study. Clinical Genetics. PMID 31093973 DOI: 10.1111/Cge.13529  0.32
2019 Guerreiro R, Escott-Price V, Hernandez DG, Kun-Rodrigues C, Ross OA, Orme T, Neto JL, Carmona S, Dehghani N, Eicher JD, Shepherd C, Parkkinen L, Darwent L, Heckman MG, Scholz SW, ... ... Marder K, et al. Heritability and genetic variance of dementia with Lewy bodies. Neurobiology of Disease. PMID 30953760 DOI: 10.1016/J.Nbd.2019.04.004  0.395
2019 Peterson B, Armstrong M, Galasko D, Galvin JE, Goldman J, Irwin D, Paulson H, Kaufer D, Leverenz J, Lunde A, McKeith IG, Siderowf A, Taylor A, Amodeo K, Barrett M, ... ... Marder K, et al. Lewy Body Dementia Association's Research Centers of Excellence Program: Inaugural Meeting Proceedings. Alzheimer's Research & Therapy. 11: 23. PMID 30867052 DOI: 10.1186/S13195-019-0476-1  0.35
2019 Alcalay RN, Mallett V, Vanderperre B, Tavassoly O, Dauvilliers Y, Wu RYJ, Ruskey JA, Leblond CS, Ambalavanan A, Laurent SB, Spiegelman D, Dionne-Laporte A, Liong C, Levy OA, Fahn S, ... ... Marder KS, et al. SMPD1 mutations, activity, and α-synuclein accumulation in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30788890 DOI: 10.1002/Mds.27642  0.558
2018 Kun-Rodrigues C, Orme T, Carmona S, Hernandez DG, Ross OA, Eicher JD, Shepherd C, Parkkinen L, Darwent L, Heckman MG, Scholz SW, Troncoso JC, Pletnikova O, Dawson T, Rosenthal L, ... ... Marder K, et al. A comprehensive screening of copy number variability in dementia with Lewy bodies. Neurobiology of Aging. PMID 30448004 DOI: 10.1016/J.Neurobiolaging.2018.10.019  0.352
2018 Zhao C, Noble JM, Marder K, Hartman JS, Gu Y, Scarmeas N. Dietary Patterns, Physical Activity, Sleep, and Risk for Dementia and Cognitive Decline. Current Nutrition Reports. PMID 30413973 DOI: 10.1007/S13668-018-0247-9  0.301
2018 Ortega RA, Groves M, Mirelman A, Alcalay RN, Raymond D, Elango S, Mejia-Santana H, Giladi N, Marder K, Bressman SB, Saunders-Pullman R. Evidence for increased completed suicide in first-degree relatives of G2019S mutation Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 30409888 DOI: 10.1136/Jnnp-2018-319364  0.385
2018 Li X, Zeng D, Marder K, Wang Y. Constructing disease onset signatures using multi-dimensional network-structured biomarkers. Biostatistics (Oxford, England). PMID 30084874 DOI: 10.1093/Biostatistics/Kxy037  0.366
2018 Shah H, Liong C, Levy OA, Waters C, Fahn S, Marder K, Kang UJ, Wolf P, Oliva P, Zhang K, Alcalay RN, Gutierrez J. Association of Low Lysosomal Enzymes Activity With Brain Arterial Dilatation: A Pilot Study. Stroke. PMID 29986930 DOI: 10.1161/Strokeaha.118.021964  0.35
2018 Ruskey JA, Greenbaum L, Roncière L, Alam A, Spiegelman D, Liong C, Levy OA, Waters C, Fahn S, Marder KS, Chung W, Yahalom G, Israeli-Korn S, Livneh V, Fay-Karmon T, et al. Increased yield of full GBA sequencing in Ashkenazi Jews with Parkinson's disease. European Journal of Medical Genetics. PMID 29842932 DOI: 10.1016/j.ejmg.2018.05.005  0.5
2018 Mirelman A, Saunders-Pullman R, Alcalay RN, Shustak S, Thaler A, Gurevich T, Raymond D, Mejia-Santana H, Orbe Reilly M, Ozelius L, Clark L, Gana-Weisz M, Bar-Shira A, Orr-Utreger A, Bressman SB, ... Marder K, et al. Application of the Movement Disorder Society prodromal criteria in healthy G2019S-LRRK2 carriers. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29603409 DOI: 10.1002/Mds.27342  0.306
2018 Saunders-Pullman R, Mirelman A, Alcalay RN, Wang C, Ortega RA, Raymond D, Mejia-Santana H, Orbe-Reilly M, Johannes BA, Thaler A, Ozelius L, Orr-Urtreger A, Marder KS, Giladi N, Bressman SB, et al. Progression in the LRRK2-Asssociated Parkinson Disease Population. Jama Neurology. PMID 29309488 DOI: 10.1001/Jamaneurol.2017.4019  0.431
2018 Tanner C, Marder K, Eberly S, Biglan K, Oakes D, Shoulson I. Selected health and lifestyle factors, cytosine-adenine-guanine status, and phenoconversion in Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29297592 DOI: 10.1002/Mds.27239  0.384
2018 Guerreiro R, Ross OA, Kun-Rodrigues C, Hernandez DG, Orme T, Eicher JD, Shepherd CE, Parkkinen L, Darwent L, Heckman MG, Scholz SW, Troncoso JC, Pletnikova O, Ansorge O, Clarimon J, ... ... Marder K, et al. Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study. The Lancet. Neurology. 17: 64-74. PMID 29263008 DOI: 10.1016/S1474-4422(17)30400-3  0.374
2017 San Luciano M, Wang C, Ortega RA, Giladi N, Marder K, Bressman S, Saunders-Pullman R. Sex differences in LRRK2 G2019S and idiopathic Parkinson's Disease. Annals of Clinical and Translational Neurology. 4: 801-810. PMID 29159192 DOI: 10.1002/Acn3.489  0.417
2017 Corriveau RA, Koroshetz WJ, Gladman JT, Jeon S, Babcock D, Bennett DA, Carmichael ST, Dickinson SL, Dickson DW, Emr M, Fillit H, Greenberg SM, Hutton ML, Knopman DS, Manly JJ, ... Marder KS, et al. Alzheimer's Disease-Related Dementias Summit 2016: National research priorities. Neurology. PMID 29117955 DOI: 10.1212/Wnl.0000000000004717  0.407
2017 Sklerov M, Kang UJ, Liong C, Clark L, Marder K, Pauciulo M, Nichols WC, Chung WK, Honig LS, Cortes E, Vonsattel JP, Alcalay RN. Frequency of GBA variants in autopsy-proven multiple system atrophy. Movement Disorders Clinical Practice. 4: 574-581. PMID 28966932 DOI: 10.1002/Mdc3.12481  0.767
2017 Lee AJ, Marder K, Alcalay RN, Mejia-Santana H, Orr-Urtreger A, Giladi N, Bressman S, Wang Y. Estimation of genetic risk function with covariates in the presence of missing genotypes. Statistics in Medicine. PMID 28656686 DOI: 10.1002/Sim.7376  0.369
2017 Garcia TP, Marder K. Statistical Approaches to Longitudinal Data Analysis in Neurodegenerative Diseases: Huntington's Disease as a Model. Current Neurology and Neuroscience Reports. 17: 14. PMID 28229396 DOI: 10.1007/S11910-017-0723-4  0.383
2016 Kurlan R, Ravina B, Eberly S, Lang AE, Tanner CM, Marek K, Marder K, Beck J, Elliott R, Oakes D, Shoulson I. Early Clinical Predictors of Treatment-Resistant and Functional Outcomes in Parkinson's Disease. Movement Disorders Clinical Practice. 3: 53-58. PMID 30363507 DOI: 10.1002/Mdc3.12273  0.383
2016 McGarry A, McDermott M, Kieburtz K, de Blieck EA, Beal F, Marder K, Ross C, Shoulson I, Gilbert P, Mallonee WM, Guttman M, Wojcieszek J, Kumar R, LeDoux MS, Jenkins M, et al. A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease. Neurology. PMID 27913695 DOI: 10.1212/Wnl.0000000000003478  0.302
2016 Devanand DP, Pelton GH, D'Antonio K, Strickler JG, Kreisl WC, Noble J, Marder K, Skomorowsky A, Huey ED. Low-dose Lithium Treatment for Agitation and Psychosis in Alzheimer Disease and Frontotemporal Dementia: A Case Series. Alzheimer Disease and Associated Disorders. PMID 27819842 DOI: 10.1097/Wad.0000000000000161  0.351
2016 Swan M, Doan N, Ortega RA, Barrett M, Nichols W, Ozelius L, Soto-Valencia J, Boschung S, Deik A, Sarva H, Cabassa J, Johannes B, Raymond D, Marder K, Giladi N, et al. Neuropsychiatric characteristics of GBA-associated Parkinson disease. Journal of the Neurological Sciences. 370: 63-69. PMID 27772789 DOI: 10.1016/J.Jns.2016.08.059  0.417
2016 Kun-Rodrigues C, Ross OA, Orme T, Shepherd C, Parkkinen L, Darwent L, Hernandez D, Ansorge O, Clark LN, Honig LS, Marder K, Lemstra A, Scheltens P, van der Flier W, Louwersheimer E, et al. Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies. Neurobiology of Aging. PMID 27666590 DOI: 10.1016/J.Neurobiolaging.2016.08.023  0.369
2016 Mirelman A, Bernad-Elazari H, Thaler A, Giladi-Yacobi E, Gurevich T, Gana-Weisz M, Saunders-Pullman R, Raymond D, Doan N, Bressman SB, Marder KS, Alcalay RN, Rao AK, Berg D, Brockmann K, et al. Arm swing as a potential new prodromal marker of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 27430880 DOI: 10.1002/Mds.26720  0.602
2016 Alcalay RN, Levy OA, Wolf P, Oliva P, Zhang XK, Waters CH, Fahn S, Kang U, Liong C, Ford B, Mazzoni P, Kuo S, Johnson A, Xiong L, Rouleau GA, ... ... Marder KS, et al. SCARB2 variants and glucocerebrosidase activity in Parkinson's disease. Npj Parkinson's Disease. 2. PMID 27110593 DOI: 10.1038/Npjparkd.2016.4  0.447
2016 Terrelonge M, Marder KS, Weintraub D, Alcalay RN. CSF β-Amyloid 1-42 Predicts Progression to Cognitive Impairment in Newly Diagnosed Parkinson Disease. Journal of Molecular Neuroscience : Mn. 58: 88-92. PMID 26330275 DOI: 10.1007/S12031-015-0647-X  0.391
2016 Liu X, Marder K, Stern Y, Dooneief G, Bell K, Todak G, Joseph M, Elsadr W, Williams JB, Ehrhardt A, Stein Z, Mayeux R. Gender Differences in HIV-Related Neurological Progression in a Cohort of Injecting Drug Users Followed for 3.5 Years. Journal of Neuro-Aids. 1: 17-30. PMID 16873176 DOI: 10.1300/J128V01N04_03  0.501
2016 Rao AK, Porciuncula F, Marder KS. E9 Impairment in gait speed modulation associated with functional mobility in huntington’s disease Journal of Neurology, Neurosurgery & Psychiatry. 87: A48.2-A48. DOI: 10.1136/Jnnp-2016-314597.135  0.529
2015 Chen H, Marder K. Milk consumption and the risk of nigral degeneration. Neurology. PMID 26658908 DOI: 10.1212/Wnl.0000000000002268  0.383
2015 Guerreiro R, Escott-Price V, Darwent L, Parkkinen L, Ansorge O, Hernandez DG, Nalls MA, Clark L, Honig L, Marder K, van der Flier W, Holstege H, Louwersheimer E, Lemstra A, Scheltens P, et al. Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases. Neurobiology of Aging. PMID 26643944 DOI: 10.1016/J.Neurobiolaging.2015.10.028  0.454
2015 Biglan KM, Shoulson I, Kieburtz K, Oakes D, Kayson E, Shinaman MA, Zhao H, Romer M, Young A, Hersch S, Penney J, Marder K, Paulsen J, Quaid K, et al. Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials. Jama Neurology. 1-9. PMID 26569098 DOI: 10.1001/Jamaneurol.2015.2736  0.403
2015 Wang Y, Liang B, Tong X, Marder K, Bressman S, Orr-Urtreger A, Giladi N, Zeng D. Efficient Estimation of Nonparametric Genetic Risk Function with Censored Data. Biometrika. 102: 515-532. PMID 26412864 DOI: 10.1093/Biomet/Asv030  0.32
2015 Liu D, Long JD, Zhang Y, Raymond LA, Marder K, Rosser A, McCusker EA, Mills JA, Paulsen JS. Motor onset and diagnosis in Huntington disease using the diagnostic confidence level. Journal of Neurology. PMID 26410751 DOI: 10.1007/S00415-015-7900-7  0.351
2015 Saunders-Pullman R, Alcalay RN, Mirelman A, Wang C, Luciano MS, Ortega RA, Glickman A, Raymond D, Mejia-Santana H, Doan N, Johannes B, Yasinovsky K, Ozelius L, Clark L, Orr-Utreger A, ... Marder K, et al. REM sleep behavior disorder, as assessed by questionnaire, in G2019S LRRK2 mutation PD and carriers. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26366513 DOI: 10.1002/Mds.26413  0.357
2015 Alcalay RN, Levy OA, Waters CC, Fahn S, Ford B, Kuo SH, Mazzoni P, Pauciulo MW, Nichols WC, Gan-Or Z, Rouleau GA, Chung WK, Wolf P, Oliva P, Keutzer J, ... Marder K, et al. Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations. Brain : a Journal of Neurology. PMID 26117366 DOI: 10.1093/Brain/Awv179  0.54
2015 Clark LN, Chan R, Cheng R, Liu X, Park N, Parmalee N, Kisselev S, Cortes E, Torres PA, Pastores GM, Vonsattel JP, Alcalay R, Marder K, Honig LL, Fahn S, et al. Gene-wise association of variants in four lysosomal storage disorder genes in neuropathologically confirmed Lewy body disease. Plos One. 10: e0125204. PMID 25933391 DOI: 10.1371/Journal.Pone.0125204  0.589
2015 Mirelman A, Alcalay RN, Saunders-Pullman R, Yasinovsky K, Thaler A, Gurevich T, Mejia-Santana H, Raymond D, Gana-Weisz M, Bar-Shira A, Ozelius L, Clark L, Orr-Urtreger A, Bressman S, Marder K, et al. Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 gene. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 981-6. PMID 25809001 DOI: 10.1002/Mds.26213  0.312
2015 Beecham GW, Dickson DW, Scott WK, Martin ER, Schellenberg G, Nuytemans K, Larson EB, Buxbaum JD, Trojanowski JQ, Van Deerlin VM, Hurtig HI, Mash DC, Beach TG, Troncoso JC, Pletnikova O, ... ... Marder K, et al. PARK10 is a major locus for sporadic neuropathologically confirmed Parkinson disease. Neurology. 84: 972-80. PMID 25663231 DOI: 10.1212/Wnl.0000000000001332  0.437
2015 Gan-Or Z, Amshalom I, Kilarski LL, Bar-Shira A, Gana-Weisz M, Mirelman A, Marder K, Bressman S, Giladi N, Orr-Urtreger A. Differential effects of severe vs mild GBA mutations on Parkinson disease. Neurology. 84: 880-7. PMID 25653295 DOI: 10.1212/Wnl.0000000000001315  0.42
2015 Helmich RC, Thaler A, van Nuenen BF, Gurevich T, Mirelman A, Marder KS, Bressman S, Orr-Urtreger A, Giladi N, Bloem BR, Toni I. Reorganization of corticostriatal circuits in healthy G2019S LRRK2 carriers. Neurology. 84: 399-406. PMID 25540317 DOI: 10.1212/Wnl.0000000000001189  0.393
2015 Alcalay RN, Mejia-Santana H, Mirelman A, Saunders-Pullman R, Raymond D, Palmese C, Caccappolo E, Ozelius L, Orr-Urtreger A, Clark L, Giladi N, Bressman S, Marder K. Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease. Parkinsonism & Related Disorders. 21: 106-10. PMID 25434972 DOI: 10.1016/J.Parkreldis.2014.09.033  0.38
2015 Kalia LV, Lang AE, Hazrati LN, Fujioka S, Wszolek ZK, Dickson DW, Ross OA, Van Deerlin VM, Trojanowski JQ, Hurtig HI, Alcalay RN, Marder KS, Clark LN, Gaig C, Tolosa E, et al. Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease. Jama Neurology. 72: 100-5. PMID 25401511 DOI: 10.1001/Jamaneurol.2014.2704  0.411
2015 Sharp ME, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Orbe Reilly M, Ruiz D, Louis ED, Comella C, Nance M, Bressman S, Scott WK, Tanner C, Waters C, Fahn S, ... ... Marder KS, et al. The relationship between obsessive-compulsive symptoms and PARKIN genotype: The CORE-PD study. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 278-83. PMID 25393808 DOI: 10.1002/Mds.26065  0.53
2015 Gupte M, Alcalay RN, Mejia-Santana H, Raymond D, Saunders-Pullman R, Roos E, Orbe-Reily M, Tang MX, Mirelman A, Ozelius L, Orr-Urtreger A, Clark L, Giladi N, Bressman S, Marder K. Interest in genetic testing in Ashkenazi Jewish Parkinson's disease patients and their unaffected relatives. Journal of Genetic Counseling. 24: 238-46. PMID 25127731 DOI: 10.1007/S10897-014-9756-X  0.397
2015 Seifan A, Marder KS, Mez J, Noble JM, Cortes EP, Vonsattel JP, Honig LS. Hippocampal laminar distribution of tau relates to Alzheimer's disease and age of onset. Journal of Alzheimer's Disease : Jad. 43: 315-24. PMID 25079799 DOI: 10.3233/Jad-140279  0.356
2015 Alcalay RN, Mejia-Santana H, Mirelman A, Saunders-Pullman R, Raymond D, Palmese C, Caccappolo E, Ozelius L, Orr-Urtreger A, Clark L, Giladi N, Bressman S, Marder K, Tang MX, Santana HM, ... ... Marder KS, et al. Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease Parkinsonism and Related Disorders. 21: 106-110. DOI: 10.1016/j.parkreldis.2014.09.033  0.474
2015 Gan-Or Z, Amshalom I, Bar-Shira A, Gana-Weisz M, Mirelman A, Marder K, Bressman S, Giladi N, Orr-Urtreger A. The Alzheimer disease BIN1 locus as a modifier of GBA-associated Parkinson disease Journal of Neurology. 262: 2443-2447. DOI: 10.1007/S00415-015-7868-3  0.419
2014 Saunders-Pullman R, Mirelman A, Wang C, Alcalay RN, San Luciano M, Ortega R, Raymond D, Mejia-Santana H, Ozelius L, Clark L, Orr-Utreger A, Marder K, Giladi N, Bressman SB. Olfactory identification in LRRK2 G2019S mutation carriers: a relevant marker? Annals of Clinical and Translational Neurology. 1: 670-8. PMID 25493281 DOI: 10.1002/Acn3.95  0.399
2014 Qin J, Garcia TP, Ma Y, Tang MX, Marder K, Wang Y. COMBINING ISOTONIC REGRESSION AND EM ALGORITHM TO PREDICT GENETIC RISK UNDER MONOTONICITY CONSTRAINT. The Annals of Applied Statistics. 8: 1182-1208. PMID 25404955 DOI: 10.1214/14-Aoas730  0.348
2014 Rao AK, Marder KS, Uddin J, Rakitin BC. Variability in interval production is due to timing-dependent deficits in Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1516-22. PMID 25154339 DOI: 10.1002/Mds.25998  0.55
2014 Montine TJ, Koroshetz WJ, Babcock D, Dickson DW, Galpern WR, Glymour MM, Greenberg SM, Hutton ML, Knopman DS, Kuzmichev AN, Manly JJ, Marder KS, Miller BL, Phelps CH, Seeley WW, et al. Recommendations of the Alzheimer's disease-related dementias conference. Neurology. 83: 851-60. PMID 25080517 DOI: 10.1212/Wnl.0000000000000733  0.388
2014 Nalls MA, Pankratz N, Lill CM, Do CB, Hernandez DG, Saad M, DeStefano AL, Kara E, Bras J, Sharma M, Schulte C, Keller MF, Arepalli S, Letson C, Edsall C, ... ... Marder K, et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease. Nature Genetics. 46: 989-93. PMID 25064009 DOI: 10.1038/Ng.3043  0.336
2014 Bras J, Guerreiro R, Darwent L, Parkkinen L, Ansorge O, Escott-Price V, Hernandez DG, Nalls MA, Clark LN, Honig LS, Marder K, Van Der Flier WM, Lemstra A, Scheltens P, Rogaeva E, et al. Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies. Human Molecular Genetics. 23: 6139-46. PMID 24973356 DOI: 10.1093/Hmg/Ddu334  0.461
2014 Vacic V, Ozelius LJ, Clark LN, Bar-Shira A, Gana-Weisz M, Gurevich T, Gusev A, Kedmi M, Kenny EE, Liu X, Mejia-Santana H, Mirelman A, Raymond D, Saunders-Pullman R, Desnick RJ, ... ... Marder K, et al. Genome-wide mapping of IBD segments in an Ashkenazi PD cohort identifies associated haplotypes. Human Molecular Genetics. 23: 4693-702. PMID 24842889 DOI: 10.1093/Hmg/Ddu158  0.387
2014 Sharp ME, Marder KS, Côté L, Clark LN, Nichols WC, Vonsattel JP, Alcalay RN. Parkinson's disease with Lewy bodies associated with a heterozygous PARKIN dosage mutation. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 566-8. PMID 24375549 DOI: 10.1002/Mds.25792  0.442
2014 Alcalay RN, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Orbe Reilly M, Ruiz D, Louis ED, Comella CL, Nance MA, Bressman SB, Scott WK, Tanner CM, Mickel SF, Waters CH, ... ... Marder KS, et al. Cognitive and motor function in long-duration PARKIN-associated Parkinson disease. Jama Neurology. 71: 62-7. PMID 24190026 DOI: 10.1001/Jamaneurol.2013.4498  0.596
2014 Long JD, Paulsen JS, Marder K, Zhang Y, Kim JI, Mills JA. Tracking motor impairments in the progression of Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 311-9. PMID 24150908 DOI: 10.1002/Mds.25657  0.344
2014 Rao A, Uddin J, Marder K, Rakitin B. I13 Variability In Interval Production Is Due To Timing Dependent Deficits In Early Huntington's Disease Journal of Neurology, Neurosurgery & Psychiatry. 85: A62-A62. DOI: 10.1136/Jnnp-2014-309032.175  0.547
2014 Dinur T, Quinn T, Sakanaka K, Levy O, Marder KS, Waters C, Fahn S, Dorovski T, Pauciulo M, Nichols W, Rana HQ, Balwani M, Bier L, Elstein D, Zimran A, et al. Parkinson disease penetrance in patients with Gaucher disease and in glucocerebrosidase mutation carriers Molecular Genetics and Metabolism. 111: S37-S38. DOI: 10.1016/j.ymgme.2013.12.071  0.486
2013 Alcalay RN, Mirelman A, Saunders-Pullman R, Tang MX, Mejia Santana H, Raymond D, Roos E, Orbe-Reilly M, Gurevich T, Bar Shira A, Gana Weisz M, Yasinovsky K, Zalis M, Thaler A, Deik A, ... ... Marder KS, et al. Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 1966-71. PMID 24243757 DOI: 10.1002/Mds.25647  0.583
2013 Mirelman A, Heman T, Yasinovsky K, Thaler A, Gurevich T, Marder K, Bressman S, Bar-Shira A, Orr-Urtreger A, Giladi N, Hausdorff JM, Saunders-Pullman R, Shanker VL, Groves M, Palmese C, et al. Fall risk and gait in Parkinson's disease: The role of the LRRK2 G2019S mutation Movement Disorders. 28: 1683-1690. PMID 24123150 DOI: 10.1002/Mds.25587  0.564
2013 Liu X, Cheng R, Ye X, Verbitsky M, Kisselev S, Mejia-Santana H, Louis E, Cote L, Andrews H, Waters C, Ford B, Fahn S, Marder K, Lee J, Clark L. Increased Rate of Sporadic and Recurrent Rare Genic Copy Number Variants in Parkinson's Disease Among Ashkenazi Jews. Molecular Genetics & Genomic Medicine. 1: 142-154. PMID 24073418 DOI: 10.1002/Mgg3.18  0.537
2013 Marder K, Gu Y, Eberly S, Tanner CM, Scarmeas N, Oakes D, Shoulson I. Relationship of Mediterranean diet and caloric intake to phenoconversion in Huntington disease. Jama Neurology. 70: 1382-8. PMID 24000094 DOI: 10.1001/Jamaneurol.2013.3487  0.367
2013 Ramos EM, Latourelle JC, Gillis T, Mysore JS, Squitieri F, Di Pardo A, Di Donato S, Gellera C, Hayden MR, Morrison PJ, Nance M, Ross CA, Margolis RL, Gomez-Tortosa E, Ayuso C, ... ... Marder K, et al. Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset. Neurogenetics. 14: 173-9. PMID 23644918 DOI: 10.1007/S10048-013-0364-Y  0.326
2013 Nalls MA, Duran R, Lopez G, Kurzawa-Akanbi M, McKeith IG, Chinnery PF, Morris CM, Theuns J, Crosiers D, Cras P, Engelborghs S, De Deyn PP, Van Broeckhoven C, Mann DM, Snowden J, ... ... Marder K, et al. A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. Jama Neurology. 70: 727-35. PMID 23588557 DOI: 10.1001/Jamaneurol.2013.1925  0.442
2013 Lewandowski NM, Bordelon Y, Brickman AM, Angulo S, Khan U, Muraskin J, Griffith EY, Wasserman P, Menalled L, Vonsattel JP, Marder K, Small SA, Moreno H. Regional vulnerability in Huntington's disease: fMRI-guided molecular analysis in patients and a mouse model of disease. Neurobiology of Disease. 52: 84-93. PMID 23220414 DOI: 10.1016/J.Nbd.2012.11.014  0.327
2013 Devanand D, Lee J, Luchsinger J, Manly J, Marder K, Mayeux R, Scarmeas N, Schupf N, Stern Y. Lessons from epidemiologic research about risk factors, modifiers, and progression of late onset Alzheimer's Disease in New York City at Columbia University Medical Center. Journal of Alzheimer's Disease : Jad. 33: S447-55. PMID 22836187 DOI: 10.3233/Jad-2012-129041  0.569
2012 Chen T, Wang Y, Ma Y, Marder K, Langbehn DR. Predicting Disease Onset from Mutation Status Using Proband and Relative Data with Applications to Huntington's Disease. Journal of Probability and Statistics. 2012. PMID 23476655 DOI: 10.1155/2012/375935  0.35
2012 van Nuenen BF, Helmich RC, Ferraye M, Thaler A, Hendler T, Orr-Urtreger A, Mirelman A, Bressman S, Marder KS, Giladi N, van de Warrenburg BP, Bloem BR, Toni I. Cerebral pathological and compensatory mechanisms in the premotor phase of leucine-rich repeat kinase 2 parkinsonism. Brain : a Journal of Neurology. 135: 3687-98. PMID 23250886 DOI: 10.1093/Brain/Aws288  0.373
2012 Wray S, Self M, Lewis PA, Taanman JW, Ryan NS, Mahoney CJ, Liang Y, Devine MJ, Sheerin UM, Houlden H, Morris HR, Healy D, ... ... Marder KS, et al. Creation of an open-access, mutation-defined fibroblast resource for neurological disease research. Plos One. 7: e43099. PMID 22952635 DOI: 10.1371/Journal.Pone.0043099  0.317
2012 Alcalay RN, Clark LN, Marder KS, Bradley WE. Lack of association between cancer history and PARKIN genotype: a family based study in PARKIN/Parkinson's families. Genes, Chromosomes & Cancer. 51: 1109-13. PMID 22927236 DOI: 10.1002/Gcc.21995  0.315
2012 Thaler A, Mirelman A, Gurevich T, Simon E, Orr-Urtreger A, Marder K, Bressman S, Giladi N. Lower cognitive performance in healthy G2019S LRRK2 mutation carriers. Neurology. 79: 1027-32. PMID 22914834 DOI: 10.1212/Wnl.0B013E3182684646  0.405
2012 Ramos EM, Latourelle JC, Lee JH, Gillis T, Mysore JS, Squitieri F, Di Pardo A, Di Donato S, Hayden MR, Morrison PJ, Nance M, Ross CA, Margolis RL, Gomez-Tortosa E, Ayuso C, ... ... Marder K, et al. Population stratification may bias analysis of PGC-1α as a modifier of age at Huntington disease motor onset. Human Genetics. 131: 1833-40. PMID 22825315 DOI: 10.1007/S00439-012-1205-Z  0.33
2012 Marder K, Mehler MF. Development and neurodegeneration: turning HD pathogenesis on its head. Neurology. 79: 621-2. PMID 22815547 DOI: 10.1212/Wnl.0B013E3182648Bfe  0.377
2012 Lee JH, Lee JM, Ramos EM, Gillis T, Mysore JS, Kishikawa S, Hadzi T, Hendricks AE, Hayden MR, Morrison PJ, Nance M, Ross CA, Margolis RL, Squitieri F, Gellera C, ... ... Marder K, et al. TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's disease. Biochemical and Biophysical Research Communications. 424: 404-8. PMID 22771793 DOI: 10.1016/J.Bbrc.2012.06.120  0.375
2012 Cooper O, Seo H, Andrabi S, Guardia-Laguarta C, Graziotto J, Sundberg M, McLean JR, Carrillo-Reid L, Xie Z, Osborn T, Hargus G, Deleidi M, Lawson T, Bogetofte H, Perez-Torres E, ... ... Marder K, et al. Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease. Science Translational Medicine. 4: 141ra90. PMID 22764206 DOI: 10.1126/Scitranslmed.3003985  0.38
2012 Pankratz N, Beecham GW, DeStefano AL, Dawson TM, Doheny KF, Factor SA, Hamza TH, Hung AY, Hyman BT, Ivinson AJ, Krainc D, Latourelle JC, Clark LN, Marder K, Martin ER, et al. Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2. Annals of Neurology. 71: 370-84. PMID 22451204 DOI: 10.1002/Ana.22687  0.478
2012 Alcalay RN, Caccappolo E, Mejia-Santana H, Tang M-, Rosado L, Orbe Reilly M, Ruiz D, Ross B, Verbitsky M, Kisselev S, Louis E, Comella C, Colcher A, Jennings D, Nance M, ... ... Marder K, et al. Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study. Neurology. 78: 1434-40. PMID 22442429 DOI: 10.1212/Wnl.0B013E318253D54B  0.513
2012 Lee JM, Gillis T, Mysore JS, Ramos EM, Myers RH, Hayden MR, Morrison PJ, Nance M, Ross CA, Margolis RL, Squitieri F, Griguoli A, Di Donato S, Gomez-Tortosa E, Ayuso C, ... ... Marder K, et al. Common SNP-based haplotype analysis of the 4p16.3 Huntington disease gene region. American Journal of Human Genetics. 90: 434-44. PMID 22387017 DOI: 10.1016/J.Ajhg.2012.01.005  0.343
2012 Lee JM, Ramos EM, Lee JH, Gillis T, Mysore JS, Hayden MR, Warby SC, Morrison P, Nance M, Ross CA, Margolis RL, Squitieri F, Orobello S, Di Donato S, Gomez-Tortosa E, ... ... Marder K, et al. CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology. 78: 690-5. PMID 22323755 DOI: 10.1212/Wnl.0B013E318249F683  0.321
2012 Alcalay RN, Gu Y, Mejia-Santana H, Cote L, Marder KS, Scarmeas N. The association between Mediterranean diet adherence and Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 771-4. PMID 22314772 DOI: 10.1002/Mds.24918  0.408
2012 Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 349-56. PMID 22275317 DOI: 10.1002/Mds.24893  0.321
2012 Poulopoulos M, Cortes E, Vonsattel JP, Fahn S, Waters C, Cote LJ, Moskowitz C, Honig LS, Clark LN, Marder KS, Alcalay RN. Clinical and pathological characteristics of LRRK2 G2019S patients with PD. Journal of Molecular Neuroscience : Mn. 47: 139-43. PMID 22194196 DOI: 10.1007/S12031-011-9696-Y  0.587
2012 Caccappolo E, Alcalay R, Marder K, Tang M, Rosado L, Mejia-Santana H, Ruiz D, Orbe-Reilly M, Ross B, Verbitsky M, Kisselev S, Louis E, Colcher A, Comella C, Siderowf A, et al. The Effect of Parkin Mutation Status on Cognitive Functioning in EOPD Patients with Long Disease Duration: The CORE-PD Study (PD7.008) Neurology. 78: PD7.008-PD7.008. DOI: 10.1212/wnl.78.1_meetingabstracts.pd7.008  0.497
2012 Alcalay R, Rosado L, Mejia-Santana H, Orbe-Reilly M, Caccappolo E, Tang M, Ruiz D, Ross B, Verbitsky M, Kisselev S, Louis E, Comella C, Colcher A, Jennings D, Nance M, ... ... Marder K, et al. Clinical and Genetic Characteristics of Participants with Juvenile PD: The CORE-PD Study (IN10-2.001) Neurology. 78: IN10-2.001-IN10-2.00. DOI: 10.1212/Wnl.78.1_Meetingabstracts.In10-2.001  0.525
2011 Rao AK, Mazzoni P, Wasserman P, Marder K. Longitudinal Change in Gait and Motor Function in Pre-manifest Huntington's Disease. Plos Currents. 3: RRN1268. PMID 22008726 DOI: 10.1371/Currents.Rrn1268  0.519
2011 Srivastava A, Tang MX, Mejia-Santana H, Rosado L, Louis ED, Caccappolo E, Comella C, Colcher A, Siderowf A, Jennings D, Nance M, Bressman S, Scott WK, Tanner C, Mickel S, ... ... Marder K, et al. The relation between depression and parkin genotype: the CORE-PD study. Parkinsonism & Related Disorders. 17: 740-4. PMID 21856206 DOI: 10.1016/J.Parkreldis.2011.07.008  0.498
2011 Devanand DP, Pelton GH, Cunqueiro K, Sackeim HA, Marder K. A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease. International Journal of Geriatric Psychiatry. 26: 937-43. PMID 21845596 DOI: 10.1002/Gps.2630  0.333
2011 Liu X, Cheng R, Verbitsky M, Kisselev S, Browne A, Mejia-Sanatana H, Louis ED, Cote LJ, Andrews H, Waters C, Ford B, Frucht S, Fahn S, Marder K, Clark LN, et al. Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population. Bmc Medical Genetics. 12: 104. PMID 21812969 DOI: 10.1186/1471-2350-12-104  0.513
2011 McGuire V, Van Den Eeden SK, Tanner CM, Kamel F, Umbach DM, Marder K, Mayeux R, Ritz B, Ross GW, Petrovitch H, Topol B, Popat RA, Costello S, Manthripragada AD, Southwick A, et al. Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium. Journal of the Neurological Sciences. 307: 22-9. PMID 21663922 DOI: 10.1016/J.Jns.2011.05.031  0.518
2011 Rao AK, Gordon AM, Marder KS. Coordination of fingertip forces during precision grip in premanifest Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 862-9. PMID 21394785 DOI: 10.1002/Mds.23606  0.513
2011 Cho SJ, Scarmeas N, Jang TW, Marder K, Tang MX, Honig LS. Importance of symptomatic cerebral infarcts on cognitive performance in patients with Alzheimer's disease. Journal of Korean Medical Science. 26: 412-6. PMID 21394311 DOI: 10.3346/Jkms.2011.26.3.412  0.38
2011 Popat RA, Van Den Eeden SK, Tanner CM, Kamel F, Umbach DM, Marder K, Mayeux R, Ritz B, Ross GW, Petrovitch H, Topol B, McGuire V, Costello S, Manthripragada AD, Southwick A, et al. Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson's disease. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 18: 756-65. PMID 21281405 DOI: 10.1111/J.1468-1331.2011.03353.X  0.512
2011 Alcalay RN, Siderowf A, Ottman R, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Louis E, Ruiz D, Waters C, Fahn S, Cote L, Frucht S, Ford B, Orbe-Reilly M, ... ... Marder K, et al. Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study. Neurology. 76: 319-26. PMID 21205674 DOI: 10.1212/Wnl.0B013E31820882Aa  0.483
2011 Caccappolo E, Alcalay RN, Mejia-Santana H, Tang MX, Rakitin B, Rosado L, Louis ED, Comella CL, Colcher A, Jennings D, Nance MA, Bressman S, Scott WK, Tanner CM, Mickel SF, ... ... Marder KS, et al. Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD Study. Journal of the International Neuropsychological Society : Jins. 17: 91-100. PMID 21092386 DOI: 10.1017/S1355617710001190  0.568
2010 Alcalay RN, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Ross BM, Verbitsky M, Kisselev S, Louis ED, Comella C, Colcher A, Jennings D, Nance MA, Bressman SB, Scott WK, ... ... Marder K, et al. Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study. Archives of Neurology. 67: 1116-22. PMID 20837857 DOI: 10.1001/Archneurol.2010.194  0.571
2010 Lewandowski NM, Ju S, Verbitsky M, Ross B, Geddie ML, Rockenstein E, Adame A, Muhammad A, Vonsattel JP, Ringe D, Cote L, Lindquist S, Masliah E, Petsko GA, Marder K, et al. Polyamine pathway contributes to the pathogenesis of Parkinson disease. Proceedings of the National Academy of Sciences of the United States of America. 107: 16970-5. PMID 20837543 DOI: 10.1073/Pnas.1011751107  0.403
2010 Marder K. Tarenflurbil in patients with mild Alzheimer's disease. Current Neurology and Neuroscience Reports. 10: 336-7. PMID 20571933 DOI: 10.1007/S11910-010-0130-6  0.418
2010 Marder KS, Tang MX, Mejia-Santana H, Rosado L, Louis ED, Comella CL, Colcher A, Siderowf AD, Jennings D, Nance MA, Bressman S, Scott WK, Tanner CM, Mickel SF, Andrews HF, et al. Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study. Archives of Neurology. 67: 731-8. PMID 20558392 DOI: 10.1001/Archneurol.2010.95  0.545
2010 Gordon PH, Goetz RR, Rabkin JG, Dalton K, McElhiney M, Hays AP, Marder K, Stern Y, Mitsumoto H. A prospective cohort study of neuropsychological test performance in ALS. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 11: 312-20. PMID 20225929 DOI: 10.3109/17482961003622585  0.483
2010 Marder K. Cognitive impairment and dementia in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. S110-6. PMID 20187235 DOI: 10.1002/Mds.22787  0.428
2010 Fahn S, Marder K, Côté L. Frontiers of science and clinical advances in quality of life in Parkinson's disease. Preface. Movement Disorders : Official Journal of the Movement Disorder Society. 25: S1. PMID 20187233 DOI: 10.1002/Mds.23029  0.495
2010 Alcalay RN, Mejia-Santana H, Tang MX, Rakitin B, Rosado L, Ross B, Verbitsky M, Kisselev S, Louis ED, Comella CL, Colcher A, Jennings D, Nance MA, Bressman S, Scott WK, ... ... Marder KS, et al. Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's disease. Journal of Clinical and Experimental Neuropsychology. 32: 775-9. PMID 20182943 DOI: 10.1080/13803390903521018  0.543
2010 Rao A, Gordon A, Marder K. Platform presentation—Impairments in Precision Grip Control in Pre-symptomatic Huntington's Disease Neurotherapeutics. 7: 136-136. DOI: 10.1016/J.Nurt.2009.09.026  0.436
2009 Alcalay RN, Mejia-Santana H, Tang MX, Rosado L, Verbitsky M, Kisselev S, Ross BM, Louis ED, Comella CL, Colcher A, Jennings D, Nance MA, Bressman S, Scott WK, Tanner C, ... ... Marder KS, et al. Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease. Archives of Neurology. 66: 1517-22. PMID 20008657 DOI: 10.1001/Archneurol.2009.267  0.559
2009 Uc EY, McDermott MP, Marder KS, Anderson SW, Litvan I, Como PG, Auinger P, Chou KL, Growdon JC. Incidence of and risk factors for cognitive impairment in an early parkinson disease clinical trial cohort Neurology. 73: 1469-1477. PMID 19884574 DOI: 10.1212/Wnl.0B013E3181Bf992F  0.425
2009 Sidransky E, Nalls MA, Aasly JO, Aharon-Peretz J, Annesi G, Barbosa ER, Bar-Shira A, Berg D, Bras J, Brice A, Chen CM, Clark LN, Condroyer C, De Marco EV, Dürr A, ... ... Marder K, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. The New England Journal of Medicine. 361: 1651-61. PMID 19846850 DOI: 10.1056/Nejmoa0901281  0.535
2009 Scarmeas N, Honig LS, Choi H, Cantero J, Brandt J, Blacker D, Albert M, Amatniek JC, Marder K, Bell K, Hauser WA, Stern Y. Seizures in Alzheimer disease: who, when, and how common? Archives of Neurology. 66: 992-7. PMID 19667221 DOI: 10.1001/Archneurol.2009.130  0.451
2009 Rao AK, Louis ED, Marder KS. Clinical assessment of mobility and balance impairments in pre-symptomatic Huntington's disease. Gait & Posture. 30: 391-3. PMID 19647432 DOI: 10.1016/J.Gaitpost.2009.07.006  0.559
2009 Pankratz N, Kissell DK, Pauciulo MW, Halter CA, Rudolph A, Pfeiffer RF, Marder KS, Foroud T, Nichols WC. Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutations. Neurology. 73: 279-86. PMID 19636047 DOI: 10.1212/Wnl.0B013E3181Af7A33  0.374
2009 Clark LN, Kartsaklis LA, Wolf Gilbert R, Dorado B, Ross BM, Kisselev S, Verbitsky M, Mejia-Santana H, Cote LJ, Andrews H, Vonsattel JP, Fahn S, Mayeux R, Honig LS, Marder K. Association of glucocerebrosidase mutations with dementia with lewy bodies. Archives of Neurology. 66: 578-83. PMID 19433657 DOI: 10.1001/Archneurol.2009.54  0.615
2009 Devier DJ, Pelton GH, Tabert MH, Liu X, Cuasay K, Eisenstadt R, Marder K, Stern Y, Devanand DP. The impact of anxiety on conversion from mild cognitive impairment to Alzheimer's disease. International Journal of Geriatric Psychiatry. 24: 1335-42. PMID 19319929 DOI: 10.1002/Gps.2263  0.509
2009 Williamson J, Goldman J, Marder KS. Genetic aspects of Alzheimer disease. The Neurologist. 15: 80-6. PMID 19276785 DOI: 10.1097/Nrl.0B013E318187E76B  0.359
2009 Rao AK, Muratori L, Louis ED, Moskowitz CB, Marder KS. Clinical measurement of mobility and balance impairments in Huntington's disease: validity and responsiveness. Gait & Posture. 29: 433-6. PMID 19111470 DOI: 10.1016/J.Gaitpost.2008.11.002  0.542
2008 Louis ED, Brickman AM, DeCarli C, Small SA, Marder K, Schupf N, Brown TR. Quantitative brain measurements in community-dwelling elderly persons with mild parkinsonian signs. Archives of Neurology. 65: 1649-54. PMID 19064753 DOI: 10.1001/Archneurol.2008.504  0.324
2008 Pankratz N, Marder KS, Halter CA, Rudolph A, Shults CW, Nichols WC, Foroud T. Clinical correlates of depressive symptoms in familial Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 2216-23. PMID 18785635 DOI: 10.1002/Mds.22285  0.355
2008 Gaba A, Zhang K, Moskowitz CB, Boozer CN, Marder K. Harris-Benedict equation estimations of energy needs as compared to measured 24-h energy expenditure by indirect calorimetry in people with early to mid-stage Huntington's disease. Nutritional Neuroscience. 11: 213-8. PMID 18782481 DOI: 10.1179/147683008X344129  0.316
2008 Marder K. Donepezil in patients with subcortical vascular cognitive impairment. Current Neurology and Neuroscience Reports. 8: 361-2. PMID 18713570 DOI: 10.1007/S11910-008-0056-4  0.377
2008 Gambetti P, Dong Z, Yuan J, Xiao X, Zheng M, Alshekhlee A, Castellani R, Cohen M, Barria MA, Gonzalez-Romero D, Belay ED, Schonberger LB, Marder K, Harris C, Burke JR, et al. A novel human disease with abnormal prion protein sensitive to protease. Annals of Neurology. 63: 697-708. PMID 18571782 DOI: 10.1002/Ana.21420  0.389
2008 Wang Y, Clark LN, Louis ED, Mejia-Santana H, Harris J, Cote LJ, Waters C, Andrews H, Ford B, Frucht S, Fahn S, Ottman R, Rabinowitz D, Marder K. Risk of Parkinson disease in carriers of parkin mutations: estimation using the kin-cohort method. Archives of Neurology. 65: 467-74. PMID 18413468 DOI: 10.1001/Archneur.65.4.467  0.565
2008 Rao AK, Muratori L, Louis ED, Moskowitz CB, Marder KS. Spectrum of gait impairments in presymptomatic and symptomatic Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 1100-7. PMID 18412252 DOI: 10.1002/Mds.21987  0.573
2008 Louis ED, Marder K, Tabert MH, Devanand DP. Mild Parkinsonian signs are associated with lower olfactory test scores in the community-dwelling elderly. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 524-30. PMID 18098296 DOI: 10.1002/Mds.21777  0.422
2008 Cho S, Scarmeas N, Marder K, Honig LS. P1-230: Frontal infarcts are associated with executive and language impairments in patients with Alzheimer's disease Alzheimer's & Dementia. 4: T279-T279. DOI: 10.1016/J.Jalz.2008.05.819  0.373
2007 Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 69: 1789-99. PMID 17914061 DOI: 10.1212/01.Wnl.0000287431.88658.8B  0.303
2007 Clark LN, Ross BM, Wang Y, Mejia-Santana H, Harris J, Louis ED, Cote LJ, Andrews H, Fahn S, Waters C, Ford B, Frucht S, Ottman R, Marder K. Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease. Neurology. 69: 1270-7. PMID 17875915 DOI: 10.1212/01.Wnl.0000276989.17578.02  0.499
2007 Gordon PH, Wang Y, Doorish C, Lewis M, Battista V, Mitsumoto H, Marder K. A screening assessment of cognitive impairment in patients with ALS. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 8: 362-5. PMID 17852014 DOI: 10.1080/17482960701500817  0.317
2007 Marder K. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. Current Neurology and Neuroscience Reports. 7: 363-5. PMID 17764624 DOI: 10.1007/S11910-007-0056-9  0.365
2007 Ritz B, Ascherio A, Checkoway H, Marder KS, Nelson LM, Rocca WA, Ross GW, Strickland D, Van Den Eeden SK, Gorell J. Pooled analysis of tobacco use and risk of Parkinson disease. Archives of Neurology. 64: 990-7. PMID 17620489 DOI: 10.1001/Archneur.64.7.990  0.349
2007 Anderson KE, Brickman AM, Flynn J, Scarmeas N, Van Heertum R, Sackeim H, Marder KS, Bell K, Moeller JR, Stern Y. Impairment of nonverbal recognition in Alzheimer disease: a PET O-15 study. Neurology. 69: 32-41. PMID 17538034 DOI: 10.1212/01.Wnl.0000266561.47619.23  0.413
2007 Aarsland D, Kvaløy JT, Andersen K, Larsen JP, Tang MX, Lolk A, Kragh-Sørensen P, Marder K. The effect of age of onset of PD on risk of dementia. Journal of Neurology. 254: 38-45. PMID 17508138 DOI: 10.1007/S00415-006-0234-8  0.43
2007 Clark LN, Haamer E, Mejia-Santana H, Harris J, Lesage S, Durr A, Bs SJ, Hedrich K, Louis ED, Cote LJ, Andrews H, Fahn S, Waters C, Ford B, Frucht S, ... ... Marder K, et al. Construction and validation of a Parkinson's disease mutation genotyping array for the Parkin gene. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 932-7. PMID 17415800 DOI: 10.1002/Mds.21419  0.56
2007 Brew BJ, Halman M, Catalan J, Sacktor N, Price RW, Brown S, Atkinson H, Clifford DB, Simpson D, Torres G, Hall C, Power C, Marder K, Mc Arthur JC, Symonds W, et al. Factors in AIDS dementia complex trial design: results and lessons from the abacavir trial. Plos Clinical Trials. 2: e13. PMID 17401456 DOI: 10.1371/Journal.Pctr.0020013  0.304
2007 Ravina B, Marder K, Fernandez HH, Friedman JH, McDonald W, Murphy D, Aarsland D, Babcock D, Cummings J, Endicott J, Factor S, Galpern W, Lees A, Marsh L, Stacy M, et al. Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 1061-8. PMID 17266092 DOI: 10.1002/Mds.21382  0.399
2007 Sevigny JJ, Albert SM, McDermott MP, Schifitto G, McArthur JC, Sacktor N, Conant K, Selnes OA, Stern Y, McClernon DR, Palumbo D, Kieburtz K, Riggs G, Cohen B, Marder K, et al. An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection. Archives of Neurology. 64: 97-102. PMID 17210815 DOI: 10.1001/Archneur.64.1.97  0.452
2007 Nichols WC, Marek DK, Pauciulo MW, Pankratz N, Halter CA, Rudolph A, Shults CW, Wojcieszek J, Foroud T, Shults C, Marshall F, Oakes D, Shinaman A, Marder K, Conneally PM, et al. R1514Q substitution in Lrrk2 is not a pathogenic Parkinson's disease mutation Movement Disorders. 22: 254-257. PMID 17149721 DOI: 10.1002/Mds.21233  0.404
2007 Yuanjia W, Clark LN, Marder K, Rabinowitz D. Nonparametric estimation of age-at-onset distributions from censored kin-cohort data Biometrika. 94: 403-414. DOI: 10.1093/Biomet/Asm027  0.321
2006 Pankratz N, Pauciulo MW, Elsaesser VE, Marek DK, Halter CA, Rudolph A, Shults CW, Foroud T, Nichols WC, Shults C, Marshall F, Oakes D, Shinaman A, Marder K, Conneally PM, et al. Mutations in LRRK2 other than G2019S are rare in a north-American based sample of familial Parkinson's didease Movement Disorders. 21: 2257-2260. PMID 17078063 DOI: 10.1002/Mds.21162  0.353
2006 Elbaz A, Nelson LM, Payami H, Ioannidis JP, Fiske BK, Annesi G, Carmine Belin A, Factor SA, Ferrarese C, Hadjigeorgiou GM, Higgins DS, Kawakami H, Krüger R, Marder KS, Mayeux RP, et al. Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study. The Lancet. Neurology. 5: 917-23. PMID 17052658 DOI: 10.1016/S1474-4422(06)70579-8  0.478
2006 Clark LN, Wang Y, Karlins E, Saito L, Mejia-Santana H, Harris J, Louis ED, Cote LJ, Andrews H, Fahn S, Waters C, Ford B, Frucht S, Ottman R, Marder K. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease. Neurology. 67: 1786-91. PMID 17050822 DOI: 10.1212/01.Wnl.0000244345.49809.36  0.493
2006 Marder K. Donepezil in patients with severe Alzheimer's disease: double-blind parallel-group, placebo controlled study. Current Neurology and Neuroscience Reports. 6: 364-3. PMID 16928344 DOI: 10.1007/S11910-996-0015-X  0.386
2006 Amatniek JC, Hauser WA, DelCastillo-Castaneda C, Jacobs DM, Marder K, Bell K, Albert M, Brandt J, Stern Y. Incidence and predictors of seizures in patients with Alzheimer's disease. Epilepsia. 47: 867-72. PMID 16686651 DOI: 10.1111/J.1528-1167.2006.00554.X  0.467
2006 Clark LN, Afridi S, Karlins E, Wang Y, Mejia-Santana H, Harris J, Louis ED, Cote LJ, Andrews H, Fahn S, Waters C, Ford B, Frucht S, Ottman R, Marder K. Case-control study of the parkin gene in early-onset Parkinson disease. Archives of Neurology. 63: 548-52. PMID 16606767 DOI: 10.1001/Archneur.63.4.548  0.546
2006 Rippon GA, Scarmeas N, Gordon PH, Murphy PL, Albert SM, Mitsumoto H, Marder K, Rowland LP, Stern Y. An observational study of cognitive impairment in amyotrophic lateral sclerosis. Archives of Neurology. 63: 345-52. PMID 16533961 DOI: 10.1001/Archneur.63.3.345  0.487
2006 Louis ED, Schupf N, Marder K, Tang MX. Functional correlates of mild parkinsonian signs in the community-dwelling elderly: Poor balance and inability to ambulate independently Movement Disorders. 21: 411-416. PMID 16211605 DOI: 10.1002/Mds.20735  0.335
2006 Marsh L, McDonald WM, Cummings J, Ravina B, Abraham N, Babcock DJ, Black KJ, Burn D, Como P, Edwards E, Elliott R, Friedman J, Gwinn-Hardy K, Hamer RM, Kelley M, ... ... Marder KS, et al. Provisional diagnostic criteria for depression in Parkinson's disease: Report of an NINDS/NIMH Work Group Movement Disorders. 21: 148-158. PMID 16211591 DOI: 10.1002/Mds.20723  0.374
2005 Rippon GA, Marder KS. Dementia in Parkinson's disease. Advances in Neurology. 96: 95-113. PMID 16383215  0.328
2005 Scarmeas N, Brandt J, Albert M, Hadjigeorgiou G, Papadimitriou A, Dubois B, Sarazin M, Devanand D, Honig L, Marder K, Bell K, Wegesin D, Blacker D, Stern Y. Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Archives of Neurology. 62: 1601-8. PMID 16216946 DOI: 10.1001/Archneur.62.10.1601  0.517
2005 Chatterjee A, Anderson KE, Moskowitz CB, Hauser WA, Marder KS. A comparison of self-report and caregiver assessment of depression, apathy, and irritability in Huntington's disease. The Journal of Neuropsychiatry and Clinical Neurosciences. 17: 378-83. PMID 16179661 DOI: 10.1176/Jnp.17.3.378  0.341
2005 Tabert MH, Liu X, Doty RL, Serby M, Zamora D, Pelton GH, Marder K, Albers MW, Stern Y, Devanand DP. A 10-item smell identification scale related to risk for Alzheimer's disease. Annals of Neurology. 58: 155-60. PMID 15984022 DOI: 10.1002/Ana.20533  0.559
2005 Gaba AM, Zhang K, Marder K, Moskowitz CB, Werner P, Boozer CN. Energy balance in early-stage Huntington disease. The American Journal of Clinical Nutrition. 81: 1335-41. PMID 15941884 DOI: 10.1093/Ajcn/81.6.1335  0.323
2005 Scarmeas N, Albert M, Brandt J, Blacker D, Hadjigeorgiou G, Papadimitriou A, Dubois B, Sarazin M, Wegesin D, Marder K, Bell K, Honig L, Stern Y. Motor signs predict poor outcomes in Alzheimer disease. Neurology. 64: 1696-703. PMID 15911793 DOI: 10.1212/01.Wnl.0000162054.15428.E9  0.522
2005 Rao AK, Quinn L, Marder KS. Reliability of spatiotemporal gait outcome measures in Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 1033-7. PMID 15838854 DOI: 10.1002/Mds.20482  0.459
2005 Louis ED, Schupf N, Manly J, Marder K, Tang MX, Mayeux R. Association between mild parkinsonian signs and mild cognitive impairment in a community. Neurology. 64: 1157-61. PMID 15824340 DOI: 10.1212/01.Wnl.0000156157.97411.5E  0.43
2005 Levy G, Louis ED, Cote L, Perez M, Mejia-Santana H, Andrews H, Harris J, Waters C, Ford B, Frucht S, Fahn S, Marder K. Contribution of aging to the severity of different motor signs in Parkinson disease. Archives of Neurology. 62: 467-72. PMID 15767513 DOI: 10.1001/Archneur.62.3.467  0.558
2005 Rippon GA, Staugaitis SM, Chin SS, Goldman JE, Marder K. Corticobasal syndrome with novel argyrophilic glial inclusions. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 598-602. PMID 15726537 DOI: 10.1002/Mds.20396  0.318
2005 Sevigny JJ, Chin SS, Milewski Y, Albers MW, Gordon ML, Marder K. HIV encephalitis simulating Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 610-3. PMID 15704206 DOI: 10.1002/Mds.20379  0.325
2005 Hogarth P, Kayson E, Kieburtz K, Marder K, Oakes D, Rosas D, Shoulson I, Wexler NS, Young AB, Zhao H. Interrater agreement in the assessment of motor manifestations of Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 293-7. PMID 15584032 DOI: 10.1002/Mds.20332  0.336
2005 Pressley JC, Tang MX, Marder K, Cote LJ, Mayeux R. Disparities in the recording of Parkinson's disease on death certificates. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 315-21. PMID 15580618 DOI: 10.1002/Mds.20339  0.511
2005 Clark LN, Nicolai A, Afridi S, Harris J, Mejia-Santana H, Strug L, Cote LJ, Louis ED, Andrews H, Waters C, Ford B, Frucht S, Fahn S, Mayeux R, Ottman R, ... Marder K, et al. Pilot association study of the beta-glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 100-3. PMID 15517591 DOI: 10.1002/Mds.20320  0.608
2005 Rao A, Muratori L, Marder K. 16.8 Factors underlying gait impairments in Huntington's disease Gait & Posture. 21: S103. DOI: 10.1016/S0966-6362(05)80338-8  0.52
2004 Sevigny JJ, Albert SM, McDermott MP, McArthur JC, Sacktor N, Conant K, Schifitto G, Selnes OA, Stern Y, McClernon DR, Palumbo D, Kieburtz K, Riggs G, Cohen B, Epstein LG, ... Marder K, et al. Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia. Neurology. 63: 2084-90. PMID 15596754 DOI: 10.1212/01.Wnl.0000145763.68284.15  0.453
2004 McArthur JC, McDermott MP, McClernon D, St Hillaire C, Conant K, Marder K, Schifitto G, Selnes OA, Sacktor N, Stern Y, Albert SM, Kieburtz K, deMarcaida JA, Cohen B, Epstein LG. Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy. Archives of Neurology. 61: 1687-96. PMID 15534180 DOI: 10.1001/Archneur.61.11.1687  0.437
2004 Scarmeas N, Hadjigeorgiou GM, Papadimitriou A, Dubois B, Sarazin M, Brandt J, Albert M, Marder K, Bell K, Honig LS, Wegesin D, Stern Y. Motor signs during the course of Alzheimer disease. Neurology. 63: 975-82. PMID 15452286 DOI: 10.1212/01.Wnl.0000138440.39918.0C  0.533
2004 Marder K. Memantine approved to treat moderate to severe Alzheimer's disease. Current Neurology and Neuroscience Reports. 4: 349-50. PMID 15324599 DOI: 10.1007/S11910-004-0080-Y  0.403
2004 Levy G, Louis ED, Mejia-Santana H, Côté L, Andrews H, Harris J, Waters C, Ford B, Frucht S, Fahn S, Ottman R, Marder K. Lack of familial aggregation of Parkinson disease and Alzheimer disease. Archives of Neurology. 61: 1033-9. PMID 15262733 DOI: 10.1001/Archneur.61.7.1033  0.574
2004 Clark LN, Afridi S, Mejia-Santana H, Harris J, Louis ED, Cote LJ, Andrews H, Singleton A, Wavrant De-Vrieze F, Hardy J, Mayeux R, Fahn S, Waters C, Ford B, Frucht S, ... ... Marder K, et al. Analysis of an early-onset Parkinson's disease cohort for DJ-1 mutations. Movement Disorders : Official Journal of the Movement Disorder Society. 19: 796-800. PMID 15254937 DOI: 10.1002/Mds.20131  0.613
2004 Wexler NS, Lorimer J, Porter J, Gomez F, Moskowitz C, Shackell E, Marder K, Penchaszadeh G, Roberts SA, Gayán J, Brocklebank D, Cherny SS, Cardon LR, Gray J, Dlouhy SR, et al. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proceedings of the National Academy of Sciences of the United States of America. 101: 3498-503. PMID 14993615 DOI: 10.1073/Pnas.0308679101  0.333
2004 Noe E, Marder K, Bell KL, Jacobs DM, Manly JJ, Stern Y. Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia. Movement Disorders : Official Journal of the Movement Disorder Society. 19: 60-7. PMID 14743362 DOI: 10.1002/Mds.10633  0.586
2004 Marder K. Vaccine trial in Alzheimer's disease is halted. Current Neurology and Neuroscience Reports. 3: 371-2. PMID 12914678 DOI: 10.1007/S11910-003-0018-9  0.313
2004 Pelton GH, Devanand D, Padilla M, Juszczak N, Chen C, Marder K, Roose SP, Sackeim HA, Stern Y. P1-409 The risk of dementia in sertraline treated elderly patients with depression and cognitive impairment Neurobiology of Aging. 25: S215. DOI: 10.1016/S0197-4580(04)80721-8  0.476
2004 Tabert MH, Goodkind M, Pelton GH, Vignier M, Zamora D, Marder K, Stern Y, Devanand DP. P1-067 Predictive utility of five neuropsychological measures in outpatients with mild cognitive impairment Neurobiology of Aging. 25: S114. DOI: 10.1016/S0197-4580(04)80381-6  0.446
2003 Albert SM, Flater SR, Clouse R, Todak G, Stern Y, Marder K. Medication management skill in HIV: I. Evidence for adaptation of medication management strategies in people with cognitive impairment. II. Evidence for a pervasive lay model of medication efficacy. Aids and Behavior. 7: 329-38. PMID 14586194 DOI: 10.1023/A:1025404105378  0.415
2003 Grove M, Vonsattel JP, Mazzoni P, Marder K. Huntington's disease. Science of Aging Knowledge Environment : Sage Ke. 2003: dn3. PMID 14586062 DOI: 10.1126/Sageke.2003.43.Dn3  0.409
2003 Louis ED, Levy G, Mejia-Santana H, Cote L, Andrews H, Harris J, Waters C, Ford B, Frucht S, Fahn S, Ottman R, Marder K. Risk of action tremor in relatives of tremor-dominant and postural instability gait disorder PD. Neurology. 61: 931-6. PMID 14557562 DOI: 10.1212/Wnl.61.7.931  0.464
2003 Marder K, Levy G, Louis ED, Mejia-Santana H, Cote L, Andrews H, Harris J, Waters C, Ford B, Frucht S, Fahn S, Ottman R. Familial aggregation of early- and late-onset Parkinson's disease. Annals of Neurology. 54: 507-13. PMID 14520664 DOI: 10.1002/Ana.10711  0.541
2003 Klein C, Hedrich K, Wellenbrock C, Kann M, Harris J, Marder K, Lang AE, Schwinger E, Ozelius LJ, Vieregge P, Pramstaller PP, Kramer PL. Frequency of parkin mutations in late-onset Parkinson's disease. Annals of Neurology. 54: 415-6; author reply . PMID 12953277 DOI: 10.1002/Ana.10737  0.385
2003 Caccappolo-van Vliet E, Miozzo M, Marder K, Stern Y. Where do perseverations come from? Neurocase. 9: 297-307. PMID 12925943 DOI: 10.1076/Neur.9.4.297.15550  0.47
2003 Holtzer R, Wegesin DJ, Albert SM, Marder K, Bell K, Albert M, Brandt J, Stern Y. The rate of cognitive decline and risk of reaching clinical milestones in Alzheimer disease. Archives of Neurology. 60: 1137-42. PMID 12925372 DOI: 10.1001/Archneur.60.8.1137  0.521
2003 Vliet EC, Manly J, Tang MX, Marder K, Bell K, Stern Y. The neuropsychological profiles of mild Alzheimer's disease and questionable dementia as compared to age-related cognitive decline. Journal of the International Neuropsychological Society : Jins. 9: 720-32. PMID 12901778 DOI: 10.1017/S1355617703950053  0.509
2003 Clark LN, Levy G, Tang MX, Mejia-Santana H, Ciappa A, Tycko B, Cote LJ, Louis ED, Mayeux R, Marder K. The Saitohin 'Q7R' polymorphism and tau haplotype in multi-ethnic Alzheimer disease and Parkinson's disease cohorts. Neuroscience Letters. 347: 17-20. PMID 12865131 DOI: 10.1016/S0304-3940(03)00635-9  0.549
2003 Marder K, Levy G, Louis ED, Mejia-Santana H, Cote L, Andrews H, Harris J, Waters C, Ford B, Frucht S, Fahn S, Ottman R. Accuracy of family history data on Parkinson's disease. Neurology. 61: 18-23. PMID 12847150 DOI: 10.1212/01.Wnl.0000074784.35961.C0  0.527
2003 Holtzer R, Tang MX, Devanand DP, Albert SM, Wegesin DJ, Marder K, Bell K, Albert M, Brandt J, Stern Y. Psychopathological features in Alzheimer's disease: course and relationship with cognitive status. Journal of the American Geriatrics Society. 51: 953-60. PMID 12834515 DOI: 10.1046/J.1365-2389.2003.51308.X  0.534
2003 Marder K, Albert SM, McDermott MP, McArthur JC, Schifitto G, Selnes OA, Sacktor N, Stern Y, Palumbo D, Kieburtz K, Cohen B, Orme C, Epstein LG. Inter-rater reliability of a clinical staging of HIV-associated cognitive impairment. Neurology. 60: 1467-73. PMID 12743233 DOI: 10.1212/01.Wnl.0000064172.46685.82  0.478
2003 Wheelock VL, Tempkin T, Marder K, Nance M, Myers RH, Zhao H, Kayson E, Orme C, Shoulson I. Predictors of nursing home placement in Huntington disease. Neurology. 60: 998-1001. PMID 12654967 DOI: 10.1212/01.Wnl.0000052992.58107.67  0.364
2003 Scarmeas N, Zarahn E, Anderson KE, Habeck CG, Hilton J, Flynn J, Marder KS, Bell KL, Sackeim HA, Van Heertum RL, Moeller JR, Stern Y. Association of life activities with cerebral blood flow in Alzheimer disease: implications for the cognitive reserve hypothesis. Archives of Neurology. 60: 359-65. PMID 12633147 DOI: 10.1001/Archneur.60.3.359  0.509
2003 Foroud T, Uniacke SK, Liu L, Pankratz N, Rudolph A, Halter C, Shults C, Marder K, Conneally PM, Nichols WC. Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease. Neurology. 60: 796-801. PMID 12629236 DOI: 10.1212/01.Wnl.0000049470.00180.07  0.396
2003 Anderson KE, Marder KS. An overview of psychiatric symptoms in Huntington's disease. Current Psychiatry Reports. 3: 379-88. PMID 11559474 DOI: 10.1007/S11920-996-0030-2  0.322
2002 Levy G, Tang MX, Louis ED, Côté LJ, Alfaro B, Mejia H, Stern Y, Marder K. The association of incident dementia with mortality in PD. Neurology. 59: 1708-13. PMID 12473757 DOI: 10.1212/01.Wnl.0000036610.36834.E0  0.518
2002 Levy G, Jacobs DM, Tang MX, Côté LJ, Louis ED, Alfaro B, Mejia H, Stern Y, Marder K. Memory and executive function impairment predict dementia in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 17: 1221-6. PMID 12465060 DOI: 10.1002/Mds.10280  0.58
2002 Marder K, Sandler S, Lechich A, Klager J, Albert SM. Relationship between CAG repeat length and late-stage outcomes in Huntington's disease. Neurology. 59: 1622-4. PMID 12451208 DOI: 10.1212/01.Wnl.0000035627.16789.23  0.33
2002 Clifford DB, McArthur JC, Schifitto G, Kieburtz K, McDermott MP, Letendre S, Cohen BA, Marder K, Ellis RJ, Marra CM. A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment. Neurology. 59: 1568-73. PMID 12451199 DOI: 10.1212/01.Wnl.0000034177.47015.Da  0.333
2002 Kock N, Müller B, Vieregge P, Pramstaller PP, Marder K, Abbruzzese G, Martinelli P, Lang AE, Jacobs H, Hagenah J, Harris J, Meija-Santana H, Fahn S, Hedrich K, Kann M, et al. Role of SCA2 mutations in early- and late-onset dopa-responsive parkinsonism. Annals of Neurology. 52: 257-8; author reply . PMID 12210804 DOI: 10.1002/Ana.10270  0.478
2002 Marder K, Logroscino G. The ever-stimulating association of smoking and coffee and Parkinson's disease. Annals of Neurology. 52: 261-2. PMID 12205636 DOI: 10.1002/Ana.10315  0.33
2002 Marder K. Donepezil for cognitive impairment in Parkinson's disease: a randomized controlled trial. Current Neurology and Neuroscience Reports. 2: 390-1. PMID 12169217 DOI: 10.1007/S11910-002-0063-9  0.397
2002 Marder K. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomized trial. Current Neurology and Neuroscience Reports. 2: 389-90. PMID 12169216 DOI: 10.1007/S11910-002-0062-X  0.387
2002 Brickman AM, Riba A, Bell K, Marder K, Albert M, Brandt J, Stern Y. Longitudinal assessment of patient dependence in Alzheimer disease Archives of Neurology. 59: 1304-1308. PMID 12164728 DOI: 10.1001/Archneur.59.8.1304  0.501
2002 Louis ID, Marder K, Jurewicz EC, Watner D, Levy G, Mejia-Santana H. Body mass index in essential tremor Archives of Neurology. 59: 1273-1277. PMID 12164723 DOI: 10.1001/Archneur.59.8.1273  0.3
2002 Louis ED, Levy G, Côte LJ, Mejia H, Fahn S, Marder K. Diagnosing Parkinson's disease using videotaped neurological examinations: validity and factors that contribute to incorrect diagnoses. Movement Disorders : Official Journal of the Movement Disorder Society. 17: 513-7. PMID 12112199 DOI: 10.1002/Mds.10119  0.568
2002 Levy G, Schupf N, Tang MX, Cote LJ, Louis ED, Mejia H, Stern Y, Marder K. Combined effect of age and severity on the risk of dementia in Parkinson's disease. Annals of Neurology. 51: 722-9. PMID 12112078 DOI: 10.1002/Ana.10219  0.546
2002 Schifitto G, McDermott MP, McArthur JC, Marder K, Sacktor N, Epstein L, Kieburtz K. Incidence of and risk factors for HIV-associated distal sensory polyneuropathy. Neurology. 58: 1764-8. PMID 12084874 DOI: 10.1212/Wnl.58.12.1764  0.316
2002 Galasko D, Marder K. Picking away at frontotemporal dementia. Neurology. 58: 1585-6. PMID 12058081 DOI: 10.1212/Wnl.58.11.1585  0.353
2002 Hedrich K, Marder K, Harris J, Kann M, Lynch T, Meija-Santana H, Pramstaller PP, Schwinger E, Bressman SB, Fahn S, Klein C. Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutations. Neurology. 58: 1239-46. PMID 11971093 DOI: 10.1212/Wnl.58.8.1239  0.417
2002 Scarmeas N, Brandt J, Albert M, Devanand DP, Marder K, Bell K, Ciappa A, Tycko B, Stern Y. Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease. Neurology. 58: 1182-8. PMID 11971084 DOI: 10.1212/Wnl.58.8.1182  0.503
2002 Sacktor N, McDermott MP, Marder K, Schifitto G, Selnes OA, McArthur JC, Stern Y, Albert S, Palumbo D, Kieburtz K, De Marcaida JA, Cohen B, Epstein L. HIV-associated cognitive impairment before and after the advent of combination therapy. Journal of Neurovirology. 8: 136-42. PMID 11935465 DOI: 10.1080/13550280290049615  0.392
2002 Levy G, Tang MX, Cote LJ, Louis ED, Alfaro B, Mejia H, Stern Y, Marder K. Do risk factors for Alzheimer's disease predict dementia in Parkinson's disease? An exploratory study. Movement Disorders : Official Journal of the Movement Disorder Society. 17: 250-7. PMID 11921109 DOI: 10.1002/Mds.10086  0.561
2001 Scarmeas N, Chin SS, Marder K. Cortical basal ganglionic degeneration. Science of Aging Knowledge Environment : Sage Ke. 2001: dn1. PMID 14602941 DOI: 10.1126/Sageke.2001.1.Dn1  0.367
2001 Louis ED, Levy G, Côte LJ, Mejia H, Fahn S, Marder K. Clinical correlates of action tremor in Parkinson disease. Archives of Neurology. 58: 1630-4. PMID 11594921 DOI: 10.1001/Archneur.58.10.1630  0.575
2001 Anderson KE, Louis ED, Stern Y, Marder KS. Cognitive correlates of obsessive and compulsive symptoms in Huntington's disease. The American Journal of Psychiatry. 158: 799-801. PMID 11329405 DOI: 10.1176/Appi.Ajp.158.5.799  0.496
2001 Stern Y, McDermott MP, Albert S, Palumbo D, Selnes OA, McArthur J, Sacktor N, Schifitto G, Kieburtz K, Epstein L, Marder KS. Factors associated with incident human immunodeficiency virus-dementia. Archives of Neurology. 58: 473-9. PMID 11255452 DOI: 10.1001/Archneur.58.3.473  0.5
2001 Stern Y, Jacobs D, Goldman J, Gomez-Tortosa E, Hyman BT, Liu Y, Troncoso J, Marder K, Tang MX, Brandt J, Albert M. An investigation of clinical correlates of Lewy bodies in autopsy-proven Alzheimer disease. Archives of Neurology. 58: 460-5. PMID 11255450 DOI: 10.1001/Archneur.58.3.460  0.523
2001 Schifitto G, Kieburtz K, McDermott MP, McArthur J, Marder K, Sacktor N, Palumbo D, Selnes O, Stern Y, Epstein L, Albert S. Clinical trials in HIV-associated cognitive impairment: cognitive and functional outcomes. Neurology. 56: 415-8. PMID 11171916 DOI: 10.1212/Wnl.56.3.415  0.466
2001 Kieburtz K, Penney JB, Corno P, Ranen N, Shoulson I, Feigin A, Abwender D, Greenarnyre JT, Higgins D, Marshall FJ, Goldstein J, Steinberg K, Shih C, Richard I, Hickey C, ... ... Marder K, et al. Unified huntington’s disease rating scale: Reliability and consistency Neurology. 11: 136-142. PMID 8684382 DOI: 10.1002/Mds.870110204  0.3
2001 Albert SM, Jacobs DM, Sano M, Marder K, Bell K, Devanand D, Brandt J, Albert M, Stern Y. Longitudinal Study of Quality of Life in People with Advanced Alzheimer's Disease The American Journal of Geriatric Psychiatry. 9: 160-168. DOI: 10.1097/00019442-200105000-00008  0.533
2000 Stern Y, Moeller JR, Anderson KE, Luber B, Zubin NR, DiMauro AA, Park A, Campbell CE, Marder K, Bell K, Van Heertum R, Sackeim HA. Different brain networks mediate task performance in normal aging and AD: defining compensation. Neurology. 55: 1291-7. PMID 11087770 DOI: 10.1212/Wnl.55.9.1291  0.343
2000 Massoud F, Devi G, Moroney JT, Stern Y, Lawton A, Bell K, Marder K, Mayeux R. The role of routine laboratory studies and neuroimaging in the diagnosis of dementia: a clinicopathological study. Journal of the American Geriatrics Society. 48: 1204-10. PMID 11037005 DOI: 10.1111/J.1532-5415.2000.Tb02591.X  0.608
2000 Louis ED, Anderson KE, Moskowitz C, Thorne DZ, Marder K. Dystonia-predominant adult-onset Huntington disease: association between motor phenotype and age of onset in adults. Archives of Neurology. 57: 1326-30. PMID 10987900 DOI: 10.1001/Archneur.57.9.1326  0.314
2000 Devanand DP, Michaels-Marston KS, Liu X, Pelton GH, Padilla M, Marder K, Bell K, Stern Y, Mayeux R. Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. The American Journal of Psychiatry. 157: 1399-405. PMID 10964854 DOI: 10.1176/Appi.Ajp.157.9.1399  0.632
2000 Levy G, Tang MX, Cote LJ, Louis ED, Alfaro B, Mejia H, Stern Y, Marder K. Motor impairment in PD: relationship to incident dementia and age. Neurology. 55: 539-44. PMID 10953188 DOI: 10.1212/Wnl.55.4.539  0.45
2000 Marder K, Sano M. Estrogen to treat Alzheimer's disease: too little, too late? So what's a woman to do? Neurology. 54: 2035-7. PMID 10851358 DOI: 10.1212/Wnl.54.11.2035  0.318
2000 Gordon AM, Quinn L, Reilmann R, Marder K. Coordination of prehensile forces during precision grip in Huntington's disease. Experimental Neurology. 163: 136-48. PMID 10785452 DOI: 10.1006/Exnr.2000.7348  0.32
2000 Simon DK, Mayeux R, Marder K, Kowall NW, Beal MF, Johns DR. Mitochondrial DNA mutations in complex I and tRNA genes in Parkinson's disease. Neurology. 54: 703-9. PMID 10680807 DOI: 10.1212/Wnl.54.3.703  0.505
2000 Marder K, Zhao H, Myers RH, Cudkowicz M, Kayson E, Kieburtz K, Orme C, Paulsen J, Penney JB, Siemers E, Shoulson I. Rate of functional decline in Huntington's disease. Huntington Study Group. Neurology. 54: 452-8. PMID 10668713 DOI: 10.1212/Wnl.54.2.452  0.372
2000 Sacktor N, Schifitto G, McDermott MP, Marder K, McArthur JC, Kieburtz K. Transdermal selegiline in HIV-associated cognitive impairment: pilot, placebo-controlled study. Neurology. 54: 233-5. PMID 10636157 DOI: 10.1212/Wnl.54.1.233  0.324
2000 Devi G, Ottman R, Tang MX, Marder K, Stern Y, Mayeux R. Familial aggregation of Alzheimer disease among whites, African Americans, and Caribbean Hispanics in northern Manhattan. Archives of Neurology. 57: 72-7. PMID 10634451 DOI: 10.1001/Archneur.57.1.72  0.568
2000 Louis ED, Marder K, Moskowitz C, Greene P. Arm elevation in Huntington's disease: dystonia or levitation? Movement Disorders : Official Journal of the Movement Disorder Society. 14: 1035-8. PMID 10584685 DOI: 10.1002/1531-8257(199911)14:6<1035::Aid-Mds1023>3.0.Co;2-D  0.375
2000 Devanand DP, Marder K, Stern Y, Pelton GH, Mayeux R. Olfactory deficits in mold cognitive impairment predict Alzheimer's disease on follow-up Neurobiology of Aging. 21: 271. DOI: 10.1016/S0197-4580(00)83174-7  0.594
1999 Devi G, Ottman R, Tang M, Marder K, Stern Y, Tycko B, Mayeux R. Influence of APOE genotype on familial aggregation of AD in an urban population. Neurology. 53: 789-94. PMID 10489042 DOI: 10.1212/Wnl.53.4.789  0.521
1999 Albert SM, Michaels K, Padilla M, Pelton G, Bell K, Marder K, Stern Y, Devanand DP. Functional significance of mild cognitive impairment in elderly patients without a dementia diagnosis. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 7: 213-20. PMID 10438692 DOI: 10.1097/00019442-199908000-00005  0.498
1999 Schifitto G, Sacktor N, Marder K, McDermott MP, McArthur JC, Kieburtz K, Small S, Epstein LG. Randomized trial of the platelet-activating factor antagonist lexipafant in HIV-associated cognitive impairment. Neurological AIDS Research Consortium. Neurology. 53: 391-6. PMID 10430432 DOI: 10.1212/Wnl.53.2.391  0.335
1999 Dolezal C, Meyer-Bahlburg HF, Liu X, Ehrhardt AA, Exner TM, Rabkin JG, Gorman JM, Marder K, Stern Y. Longitudinal changes in sexual risk behavior among HIV+ and HIV- male injecting drug users. The American Journal of Drug and Alcohol Abuse. 25: 281-303. PMID 10395161 DOI: 10.1081/Ada-100101861  0.415
1999 Jacobs DM, Albert SM, Sano M, del Castillo-Castañeda C, Paik MC, Marder K, Bell K, Brandt J, Albert MS, Stern Y. Assessment of cognition in advanced AD: the test for severe impairment. Neurology. 52: 1689-91. PMID 10331701 DOI: 10.1212/Wnl.52.8.1689  0.486
1999 Louis ED, Tang MX, Cote L, Alfaro B, Mejia H, Marder K. Progression of parkinsonian signs in Parkinson disease. Archives of Neurology. 56: 334-7. PMID 10190824 DOI: 10.1001/Archneur.56.3.334  0.41
1999 Marder K, Tang MX, Alfaro B, Mejia H, Cote L, Louis E, Stern Y, Mayeux R. Risk of Alzheimer's disease in relatives of Parkinson's disease patients with and without dementia. Neurology. 52: 719-24. PMID 10078716 DOI: 10.1212/Wnl.52.4.719  0.629
1999 Louis ED, Lee P, Quinn L, Marder K. Dystonia in Huntington's disease: prevalence and clinical characteristics. Movement Disorders : Official Journal of the Movement Disorder Society. 14: 95-101. PMID 9918350 DOI: 10.1002/1531-8257(199901)14:1<95::Aid-Mds1016>3.0.Co;2-8  0.368
1999 Albert SM, Weber CM, Todak G, Polanco C, Clouse R, McElhiney M, Rabkin J, Stern Y, Marder K. An observed performance test of medication management ability in HIV: Relation to neuropsychological status and medication adherence outcomes Aids and Behavior. 3: 121-128. DOI: 10.1023/A:1025483806464  0.42
1998 Devanand DP, Marder K, Michaels KS, Sackeim HA, Bell K, Sullivan MA, Cooper TB, Pelton GH, Mayeux R. A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease. The American Journal of Psychiatry. 155: 1512-20. PMID 9812111 DOI: 10.1176/Ajp.155.11.1512  0.423
1998 Dolezal C, Ehrhardt AA, Meyer-Bahlburg HF, Liu X, Exner TM, Rabkin JG, Gorman JM, Marder K, Stern Y. Sexual risk behavior changes among HIV+ and HIV-female injecting drug users over 4 years. Women & Health. 27: 1-17. PMID 9796081 DOI: 10.1300/J013V27N04_01  0.423
1998 Mirel DB, Marder K, Graziano J, Freyer G, Zhao Q, Mayeux R, Wilhelmsen KC. Characterization of the human mitochondrial aconitase gene (ACO2). Gene. 213: 205-18. PMID 9630632 DOI: 10.1016/S0378-1119(98)00188-7  0.439
1998 Devi G, Marder K, Schofield PW, Tang MX, Stern Y, Mayeux R. Validity of family history for the diagnosis of dementia among siblings of patients with late-onset Alzheimer's disease. Genetic Epidemiology. 15: 215-23. PMID 9593109 DOI: 10.1002/(Sici)1098-2272(1998)15:3<215::Aid-Gepi1>3.0.Co;2-3  0.584
1998 Marder K, Tang MX, Alfaro B, Mejia H, Cote L, Jacobs D, Stern Y, Sano M, Mayeux R. Postmenopausal estrogen use and Parkinson's disease with and without dementia. Neurology. 50: 1141-3. PMID 9566410 DOI: 10.1212/Wnl.50.4.1141  0.641
1998 Marder K, Logroscino G, Tang MX, Graziano J, Cote L, Louis E, Alfaro B, Mejia H, Slavkovich V, Mayeux R. Systemic iron metabolism and mortality from Parkinson's disease. Neurology. 50: 1138-40. PMID 9566409 DOI: 10.1212/Wnl.50.4.1138  0.49
1998 Tang MX, Stern Y, Marder K, Bell K, Gurland B, Lantigua R, Andrews H, Feng L, Tycko B, Mayeux R. The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. Jama. 279: 751-5. PMID 9508150 DOI: 10.1001/Jama.279.10.751  0.583
1998 Jacobs DM, Tang MX, Stern Y, Sano M, Marder K, Bell KL, Schofield P, Dooneief G, Gurland B, Mayeux R. Cognitive function in nondemented older women who took estrogen after menopause. Neurology. 50: 368-73. PMID 9484355 DOI: 10.1212/Wnl.50.2.368  0.486
1998 Marder K, Logroscino G, Alfaro B, Mejia H, Halim A, Louis E, Cote L, Mayeux R. Environmental risk factors for Parkinson's disease in an urban multiethnic community. Neurology. 50: 279-81. PMID 9443493 DOI: 10.1212/Wnl.50.1.279  0.518
1998 STERN Y, TANG M, JACOBS DM, SANO M, MARDER K, BELL K, DOONEIEF G, SCHOFIELD P, CÔTÉ L. Prospective comparative study of the evolution of probable Alzheimer's disease and Parkinson's disease dementia Journal of the International Neuropsychological Society. 4: 279-284. DOI: 10.1017/S1355617798002793  0.586
1997 Logroscino G, Marder K, Graziano J, Freyer G, Slavkovich V, LoIacono N, Cote L, Mayeux R. Altered systemic iron metabolism in Parkinson's disease. Neurology. 49: 714-7. PMID 9305329 DOI: 10.1212/Wnl.49.3.714  0.336
1997 Albert SM, Sano M, Marder K, Jacobs DM, Brandt J, Albert M, Stern Y. Participation in clinical trials and long-term outcomes in Alzheimer's disease. Neurology. 49: 38-43. PMID 9222167 DOI: 10.1212/Wnl.49.1.38  0.483
1997 Schofieid PW, Jacobs D, Marder K, Sana M, Stem Y. The validity of new memory complaints in the elderly Archives of Neurology. 54: 756-759. PMID 9193211 DOI: 10.1001/Archneur.1997.00550180064014  0.351
1997 Wilhelmsen K, Mirel D, Marder K, Bernstein M, Naini A, Leal SM, Cote LJ, Tang MX, Freyer G, Graziano J, Mayeux R. Is there a genetic susceptibility locus for Parkinson's disease on chromosome 22q13? Annals of Neurology. 41: 813-7. PMID 9189044 DOI: 10.1002/Ana.410410619  0.509
1997 Stern Y, Brandt J, Albert M, Jacobs DM, Liu X, Bell K, Marder K, Sano M, Albert S, Del-Castillo Castenada C, Bylsma F, Tycko B, Mayeux R. The absence of an apolipoprotein epsilon4 allele is associated with a more aggressive form of Alzheimer's disease. Annals of Neurology. 41: 615-20. PMID 9153523 DOI: 10.1002/Ana.410410510  0.614
1997 Schofield PW, Marder K, Dooneief G, Jacobs DM, Sano M, Stern Y. Association of subjective memory complaints with subsequent cognitive decline in community-dwelling elderly individuals with baseline cognitive impairment. The American Journal of Psychiatry. 154: 609-15. PMID 9137114 DOI: 10.1176/Ajp.154.5.609  0.444
1997 Devanand DP, Jacobs DM, Tang MX, Del Castillo-Castaneda C, Sano M, Marder K, Bell K, Bylsma FW, Brandt J, Albert M, Stern Y. The course of psychopathologic features in mild to moderate Alzheimer disease. Archives of General Psychiatry. 54: 257-63. PMID 9075466 DOI: 10.1001/Archpsyc.1997.01830150083012  0.519
1997 Louis ED, Marder K, Cote L, Tang M, Mayeux R. Mortality from Parkinson disease. Archives of Neurology. 54: 260-4. PMID 9074394 DOI: 10.1001/Archneur.1997.00550150024011  0.514
1997 Stern Y, Tang MX, Albert MS, Brandt J, Jacobs DM, Bell K, Marder K, Sano M, Devanand D, Albert SM, Bylsma F, Tsai WY. Predicting time to nursing home care and death in individuals with Alzheimer disease. Jama. 277: 806-12. PMID 9052710 DOI: 10.1001/Jama.1997.03540340040030  0.484
1997 Schofield PW, Tang M, Marder K, Bell K, Dooneief G, Chun M, Sano M, Stern Y, Mayeux R. Alzheimer's disease after remote head injury: an incidence study. Journal of Neurology, Neurosurgery, and Psychiatry. 62: 119-24. PMID 9048710 DOI: 10.1136/Jnnp.62.2.119  0.535
1997 Jacobs DM, Sano M, Dooneief G, Marder K, Bell KL, Stern Y. Reply from the Authors: Preclinical AD Neurology. 48: 549-550. DOI: 10.1212/Wnl.48.2.549-C  0.484
1997 Jacobs DM, Marder K, Cote LJ, Sano M, Stern Y, Mayeux R. Reply from the Authors: Early frontal impairment as a predictor of dementia in Parkinson's disease Neurology. 48: 547-547. DOI: 10.1212/Wnl.48.2.547  0.595
1997 Tang M, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, Andrews H, Mayeux R. Effect of Oestrogen During Menopause on Risk and Age at Onset of Alzheimer's Disease Obstetrical & Gynecological Survey. 52: 37-39. DOI: 10.1097/00006254-199701000-00020  0.6
1996 Dooneief GH, Bello JA, Todak GG, Tang MX, Marder KS, Stern Y, Mayeux RP. Serial MRI in HIV Infection With and Without Neurologic Impairment. Journal of Neuro-Aids. 1: 49-57. PMID 16873178 DOI: 10.1300/J128V01N04_05  0.481
1996 Stern Y, Liu X, Albert M, Brandt J, Jacobs DM, Del Castillo-Castaneda C, Marder K, Bell K, Sano M, Bylsma F. Modeling the influence of extrapyramidal signs on the progression of Alzheimer disease. Archives of Neurology. 53: 1121-6. PMID 8912485 DOI: 10.1001/Archneur.1996.00550110061013  0.517
1996 Albert SM, Del Castillo-Castaneda C, Sano M, Jacobs DM, Marder K, Bell K, Bylsma F, Lafleche G, Brandt J, Albert M, Stern Y. Quality of life in patients with Alzheimer's disease as reported by patient proxies. Journal of the American Geriatrics Society. 44: 1342-7. PMID 8909350 DOI: 10.1111/J.1532-5415.1996.Tb01405.X  0.473
1996 Louis ED, Marder K, Cote L, Wilder D, Tang MX, Lantigua R, Gurland B, Mayeux R. Prevalence of a history of shaking in persons 65 years of age and older: diagnostic and functional correlates. Movement Disorders : Official Journal of the Movement Disorder Society. 11: 63-9. PMID 8771069 DOI: 10.1002/mds.870110112  0.442
1996 Tang MX, Tsai WY, Marder K, Mayeux R. Linear rank tests for doubly censored data. Statistics in Medicine. 14: 2555-63. PMID 8746888 DOI: 10.1002/Sim.4780142305  0.447
1996 Ramachandran G, Marder K, Tang M, Schofield PW, Chun MR, Devanand DP, Stern Y, Mayeux R. A preliminary study of apolipoprotein E genotype and psychiatric manifestations of Alzheimer's disease. Neurology. 47: 256-9. PMID 8710089 DOI: 10.1212/Wnl.47.1.256  0.574
1996 Marder K, Tang MX, Mejia H, Alfaro B, Côté L, Louis E, Groves J, Mayeux R. Risk of Parkinson's disease among first-degree relatives: A community-based study. Neurology. 47: 155-60. PMID 8710070 DOI: 10.1212/WNL.47.1.155  0.487
1996 Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, Andrews H, Mayeux R. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet (London, England). 348: 429-32. PMID 8709781 DOI: 10.1016/S0140-6736(96)03356-9  0.615
1996 Louis ED, Lynch T, Marder K, Fahn S. Reliability of patient completion of the historical section of the Unified Parkinson's Disease Rating Scale. Movement Disorders : Official Journal of the Movement Disorder Society. 11: 185-92. PMID 8684390 DOI: 10.1002/Mds.870110212  0.549
1996 Stern Y, Liu X, Albert M, Brandt J, Jacobs DM, Del Castillo-Castaneda C, Marder K, Bell K, Sano M, Bylsma F, Lafleche G, Tsai WY. Application of a growth curve approach to modeling the progression of Alzheimer's disease. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 51: M179-84. PMID 8681001 DOI: 10.1093/Gerona/51A.4.M179  0.521
1996 Dooneief G, Marder K, Tang MX, Stern Y. The Clinical Dementia Rating scale: community-based validation of "profound' and "terminal' stages. Neurology. 46: 1746-9. PMID 8649584 DOI: 10.1212/Wnl.46.6.1746  0.453
1996 Dooneief G, Marlink R, Bell K, Marder K, Renjifo B, Stern Y, Mayeux R. Neurologic consequences of HTLV-II infection in injection-drug users. Neurology. 46: 1556-60. PMID 8649548 DOI: 10.1212/Wnl.46.6.1556  0.521
1996 Logroscino G, Marder K, Cote L, Tang MX, Shea S, Mayeux R. Dietary lipids and antioxidants in Parkinson's disease: a population-based, case-control study. Annals of Neurology. 39: 89-94. PMID 8572672 DOI: 10.1002/Ana.410390113  0.509
1996 Stern Y, Liu X, Marder K, Todak G, Sano M, Malouf R, Joseph M, El-Sadr WM, Ehrhardt AA, Williams JBW, Gorman JM. Neuropsychological changes in a prospectively followed cohort of intravenous drug users with and without HIV Neuropsychiatry Neuropsychology and Behavioral Neurology. 9: 83-90. DOI: 10.7916/D8Kp9Jkv  0.453
1995 Schofield PW, Tang M, Marder K, Bell K, Dooneief G, Lantigua R, Wilder D, Gurland B, Stern Y, Mayeux R. Consistency of clinical diagnosis in a community-based longitudinal study of dementia and Alzheimer's disease. Neurology. 45: 2159-64. PMID 8848185 DOI: 10.1212/Wnl.45.12.2159  0.616
1995 Stern Y, Albert M, Brandt J, Jacobs DM, Tang MX, Marder K, Bell K, Sano M, Devanand DP, Bylsma F. Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the Predictors Study. Neurology. 44: 2300-7. PMID 7991116 DOI: 10.1212/Wnl.44.12.2300  0.536
1995 Stern Y, Liu X, Marder K, Todak G, Sano M, Ehrhardt A, Gorman J. Neuropsychological changes in a prospectively followed cohort of homosexual and bisexual men with and without HIV infection. Neurology. 45: 467-72. PMID 7898698 DOI: 10.1212/Wnl.45.3.467  0.453
1995 Marder K, Liu X, Stern Y, Dooneief G, Bell K, Schofield P, Sacktor N, Todak G, Friedman R, Ehrhardt A. Neurologic signs and symptoms in a cohort of homosexual men followed for 4.5 years. Neurology. 45: 261-7. PMID 7854523 DOI: 10.1212/Wnl.45.2.261  0.452
1995 Marder K, Richards M, Bello J, Bell K, Sano M, Miller L, Folstein M, Albert M, Stern Y. Clinical correlates of Alzheimer's disease with and without silent radiographic abnormalities. Archives of Neurology. 52: 146-51. PMID 7848122 DOI: 10.1001/Archneur.1995.00540260050015  0.504
1995 Sacktor N, Prohovnik I, Van Heertum RL, Dooneief G, Gorman J, Marder K, Todak G, Stern Y, Mayeux R. Cerebral single-photon emission computed tomography abnormalities in human immunodeficiency virus type 1-infected gay men without cognitive impairment. Archives of Neurology. 52: 607-11. PMID 7763210 DOI: 10.1001/Archneur.1995.00540300081017  0.551
1995 Jacobs DM, Sano M, Dooneief G, Marder K, Bell KL, Stern Y. Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology. 45: 957-62. PMID 7746414 DOI: 10.1212/Wnl.45.5.957  0.516
1995 Albert SM, Marder K, Dooneief G, Bell K, Sano M, Todak G, Stern Y. Neuropsychologic impairment in early HIV infection. A risk factor for work disability. Archives of Neurology. 52: 525-30. PMID 7733849 DOI: 10.1001/Archneur.1995.00540290115027  0.443
1995 Jacobs DM, Marder K, Côté LJ, Sano M, Stern Y, Mayeux R. Neuropsychological characteristics of preclinical dementia in Parkinson's disease. Neurology. 45: 1691-6. PMID 7675228 DOI: 10.1212/Wnl.45.9.1691  0.66
1995 Marder K, Tang MX, Cote L, Stern Y, Mayeux R. The frequency and associated risk factors for dementia in patients with Parkinson's disease. Archives of Neurology. 52: 695-701. PMID 7619026 DOI: 10.1001/Archneur.1995.00540310069018  0.64
1995 Sacktor N, Liu X, Popescu M, Marder K, Stern Y, Mayeux R. Serum neopterin level predicts HIV-related mortality but not progression to AIDS or development of neurological disease in gay men and parenteral drug users. Archives of Neurology. 52: 676-9. PMID 7619023 DOI: 10.1001/Archneur.1995.00540310046015  0.542
1995 Sano M, Devanand DP, Richards M, Miller LW, Marder K, Bell K, Dooneief G, Bylsma FW, Lafleche G, Albert M. A standardized technique for establishing onset and duration of symptoms of Alzheimer's disease. Archives of Neurology. 52: 961-6. PMID 7575223 DOI: 10.1001/Archneur.1995.00540340045012  0.412
1995 Mayeux R, Marder K, Cote LJ, Denaro J, Hemenegildo N, Mejia H, Tang MX, Lantigua R, Wilder D, Gurland B. The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. American Journal of Epidemiology. 142: 820-7. PMID 7572958 DOI: 10.1093/Oxfordjournals.Aje.A117721  0.501
1995 Louis ED, Marder K, Cote L, Pullman S, Ford B, Wilder D, Tang MX, Lantigua R, Gurland B, Mayeux R. Differences in the prevalence of essential tremor among elderly African Americans, whites, and Hispanics in northern Manhattan, NY. Archives of Neurology. 52: 1201-5. PMID 7492295 DOI: 10.1001/Archneur.1995.00540360079019  0.419
1995 Marder K, Liu X, Stern Y, Malouf R, Dooneief G, Bell K, Todak G, Joseph M, Sorrell S, el Sadr W. Risk of human immunodeficiency virus type 1-related neurologic disease in a cohort of intravenous drug users. Archives of Neurology. 52: 1174-82. PMID 7492292 DOI: 10.1001/Archneur.1995.00540360052016  0.458
1995 Sacktor N, Van Heertum RL, Dooneief G, Gorman J, Khandji A, Marder K, Nour R, Todak G, Stern Y, Mayeux R. A comparison of cerebral SPECT abnormalities in HIV-positive homosexual men with and without cognitive impairment. Archives of Neurology. 52: 1170-3. PMID 7492291 DOI: 10.1001/Archneur.1995.00540360048015  0.532
1995 Marder K, Alfaro B, Maestre G, Halim A, Cote L, Tang M, Mejia H, Tycko B, Mayeux R. Apolipoprotein E4 in Parkinson's disease Neurology. 45: 1025-1025. DOI: 10.1212/WNL.45.5.1025-b  0.439
1994 Mayeux R, Tang MX, Marder K, Côté LJ, Stern Y. Smoking and Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 9: 207-12. PMID 8196685 DOI: 10.1002/Mds.870090215  0.558
1994 Richards M, Marder K, Cote L, Mayeux R. Interrater reliability of the Unified Parkinson's Disease Rating Scale motor examination Movement Disorders. 9: 89-91. PMID 8139610 DOI: 10.1002/Mds.870090114  0.47
1994 Richards M, Marder K, Cote L, Mayeux R. Reliability of symptom onset assessment in Parkinson's disease Movement Disorders. 9: 340-342. PMID 8041376 DOI: 10.1002/Mds.870090313  0.481
1994 Marder K, Maestre G, Cote L, Mejia H, Alfaro B, Halim A, Tang M, Tycko B, Mayeux R. The apolipoprotein epsilon 4 allele in Parkinson's disease with and without dementia. Neurology. 44: 1330-1. PMID 8035940 DOI: 10.1212/Wnl.44.7.1330  0.569
1994 Jacobs D, Sano M, Marder K, Bell K, Bylsma F, Lafleche G, Albert M, Brandt J, Stern Y. Age at onset of Alzheimer's disease: relation to pattern of cognitive dysfunction and rate of decline. Neurology. 44: 1215-20. PMID 8035918 DOI: 10.1212/Wnl.44.7.1215  0.537
1994 Lynch T, Sano M, Marder KS, Bell KL, Foster NL, Defendini RF, Sima AA, Keohane C, Nygaard TG, Fahn S. Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex. Neurology. 44: 1878-84. PMID 7936241 DOI: 10.1212/Wnl.44.10.1878  0.515
1994 Stern Y, Mayeux R, Marder K. Dementia in Parkinson's disease Neurology. 44: 1553-1553. DOI: 10.1212/Wnl.44.8.1553-A  0.64
1994 Albert SM, Todak G, Elkin E, Marder K, Dooneief G, Stern Y. Time allocation and disability in HIV infection: A correlational study Journal of Occupational Science. 1: 21-30. DOI: 10.1080/14427591.1994.9686389  0.461
1993 Mayeux R, Ottman R, Tang MX, Noboa-Bauza L, Marder K, Gurland B, Stern Y. Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and their first-degree relatives Annals of Neurology. 33: 494-501. PMID 8498827 DOI: 10.1002/Ana.410330513  0.573
1993 Richards M, Stern Y, Marder K, Cote L, Mayeux R. Relationships between extrapyramidal signs and cognitive function in a community-dwelling cohort of patients with Parkinson's disease and normal elderly individuals. Annals of Neurology. 33: 267-74. PMID 8498810 DOI: 10.1002/Ana.410330307  0.588
1993 Stern Y, Folstein M, Albert M, Richards M, Miller L, Bylsma F, Lafleche G, Marder K, Bell K, Sano M. Multicenter study of predictors of disease course in Alzheimer disease (the "predictors study"). I. Study design, cohort description, and intersite comparisons. Alzheimer Disease and Associated Disorders. 7: 3-21. PMID 8481224 DOI: 10.1097/00002093-199307010-00002  0.539
1993 Richards M, Folstein M, Albert M, Miller L, Bylsma F, Lafleche G, Marder K, Bell K, Sano M, Devanand D. Multicenter study of predictors of disease course in Alzheimer disease (the "predictors study"). II. Neurological, psychiatric, and demographic influences on baseline measures of disease severity. Alzheimer Disease and Associated Disorders. 7: 22-32. PMID 8481223 DOI: 10.1097/00002093-199307010-00003  0.442
1993 Sano M, Bell K, Marder K, Stricks L, Stern Y, Mayeux R. Safety and efficacy of oral physostigmine in the treatment of Alzheimer disease. Clinical Neuropharmacology. 16: 61-9. PMID 8422658 DOI: 10.1097/00002826-199302000-00007  0.559
1993 Richards M, Bell K, Dooneief G, Marder K, Sano M, Mayeux R, Stern Y. Patterns of neuropsychological performance in Alzheimer's disease patients with and without extrapyramidal signs. Neurology. 43: 1708-11. PMID 8414017 DOI: 10.1212/Wnl.43.9.1708  0.586
1993 Stern Y, Marder K, Tang MX, Mayeux R. Antecedent clinical features associated with dementia in Parkinson's disease. Neurology. 43: 1690-2. PMID 8414013 DOI: 10.1212/Wnl.43.9.1690  0.652
1993 Mayeux R, Stern Y, Tang MX, Todak G, Marder K, Sano M, Richards M, Stein Z, Ehrhardt AA, Gorman JM. Mortality risks in gay men with human immunodeficiency virus infection and cognitive impairment. Neurology. 43: 176-82. PMID 8093809 DOI: 10.1212/WNL.43.1_Part_1.176  0.525
1992 Marder K, Mayeux R. The epidemiology of dementia in patients with Parkinson's disease. Advances in Experimental Medicine and Biology. 295: 439-45. PMID 1776581 DOI: 10.1007/978-1-4757-0145-6_25  0.569
1992 Dooneief G, Bello J, Todak G, Mun IK, Marder K, Malouf R, Gorman J, Hilal S, Stern Y, Mayeux R. A prospective controlled study of magnetic resonance imaging of the brain in gay men and parenteral drug users with human immunodeficiency virus infection. Archives of Neurology. 49: 38-43. PMID 1728262 DOI: 10.1001/Archneur.1992.00530250042014  0.512
1992 Mayeux R, Denaro J, Hemenegildo N, Marder K, Tang MX, Cote LJ, Stern Y. A population-based investigation of Parkinson's disease with and without dementia. Relationship to age and gender. Archives of Neurology. 49: 492-7. PMID 1580811 DOI: 10.1001/Archneur.1992.00530290076015  0.631
1992 Devanand DP, Miller L, Richards M, Marder K, Bell K, Mayeux R, Stern Y. The Columbia University Scale for Psychopathology in Alzheimer's disease. Archives of Neurology. 49: 371-6. PMID 1558517 DOI: 10.1001/Archneur.1992.00530280051022  0.619
1992 Dooneief G, Mirabello E, Bell K, Marder K, Stern Y, Mayeux R. An estimate of the incidence of depression in idiopathic Parkinson's disease. Archives of Neurology. 49: 305-7. PMID 1536634 DOI: 10.1001/Archneur.1992.00530270125028  0.541
1992 Marder K, Stern Y, Malouf R, Tang MX, Bell K, Dooneief G, el-Sadr W, Goldstein S, Gorman J, Richards M. Neurologic and neuropsychological manifestations of human immunodeficiency virus infection in intravenous drug users without acquired immunodeficiency syndrome. Relationship to head injury. Archives of Neurology. 49: 1169-75. PMID 1444884 DOI: 10.1001/Archneur.1992.00530350083023  0.419
1992 Sano M, Bell K, Cote L, Dooneief G, Lawton A, Legler L, Marder K, Naini A, Stern Y, Mayeux R. Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer's disease. Archives of Neurology. 49: 1137-41. PMID 1444880 DOI: 10.1001/Archneur.1992.00530350051019  0.608
1992 Friedman D, Hamberger M, Stern Y, Marder K. Event-related potentials (ERPs) during repetition priming in Alzheimer's patients and young and older controls. Journal of Clinical and Experimental Neuropsychology. 14: 448-62. PMID 1400911 DOI: 10.1080/01688639208402837  0.49
1991 Richards M, Marder K, Bell K, Dooneief G, Mayeux R, Stern Y. Interrater reliability of extrapyramidal signs in a group assessed for dementia. Archives of Neurology. 48: 1147-9. PMID 1953399 DOI: 10.1001/Archneur.1991.00530230055021  0.604
1991 Marder K, Leung D, Tang M, Bell K, Dooneief G, Cote L, Stern Y, Mayeux R. Are demented patients with Parkinson's disease accurately reflected in prevalence surveys? A survival analysis. Neurology. 41: 1240-3. PMID 1866013 DOI: 10.1212/Wnl.41.8.1240  0.642
1991 Fernandez-Madrid I, Levy E, Marder K, Frangione B. Codon 618 variant of Alzheimer amyloid gene associated with inherited cerebral hemorrhage. Annals of Neurology. 30: 730-3. PMID 1763898 DOI: 10.1002/Ana.410300516  0.309
1991 Sano M, Stanley M, Lawton A, Coté L, Williams J, Stern Y, Marder K, Mayeux R. Tritiated imipramine binding. A peripheral marker for serotonin in Parkinson's disease. Archives of Neurology. 48: 1052-4. PMID 1718247 DOI: 10.1001/Archneur.1991.00530220072022  0.568
1991 Stern Y, Marder K, Bell K, Chen J, Dooneief G, Goldstein S, Mindry D, Richards M, Sano M, Williams J. Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection. III. Neurologic and neuropsychological findings. Archives of General Psychiatry. 48: 131-8. PMID 1671199 DOI: 10.1001/Archpsyc.1991.01810260039006  0.431
1991 Marder K, Stern Y. Neurological and neuropsychological aspects of HIV infection Current Opinion in Psychiatry. 4: 96-100. DOI: 10.1097/00001504-199102000-00022  0.403
1990 Sano M, Stern Y, Marder K, Mayeux R. A controlled trial of piracetam in intellectually impaired patients with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 5: 230-4. PMID 2388639 DOI: 10.1002/Mds.870050308  0.599
1990 Marder K, Flood P, Cote L, Mayeux R. A pilot study of risk factors for dementia in Parkinson's disease Movement Disorders. 5: 156-161. PMID 2325678 DOI: 10.1002/Mds.870050212  0.544
1990 Mayeux R, Chen J, Mirabello E, Marder K, Bell K, Dooneief G, Cote L, Stern Y. An estimate of the incidence of dementia in idiopathic Parkinson's disease. Neurology. 40: 1513-7. PMID 2215941 DOI: 10.1212/Wnl.40.10.1513  0.635
1988 Mayeux R, Stern Y, Rosenstein R, Marder K, Hauser A, Cote L, Fahn S. An estimate of the prevalence of dementia in idiopathic Parkinson's disease. Archives of Neurology. 45: 260-2. PMID 3341950 DOI: 10.1001/Archneur.1988.00520270034017  0.7
Show low-probability matches.